Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.3092372437652074e-36,18.36082260074782,1500.012109148208,"['RPL4', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL13A', 'RPSA', 'RPS3A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.7605142136830903e-33,0,0,69
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.944940702706072e-07,3.1696105001102954,45.43812595458852,"['COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'COX4I1', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UQCRFS1', 'ATP5MF', 'COX8A', 'ATP5PF', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS5', 'UQCRC1', 'SLC25A5', 'SLC25A4', 'SLC25A6']",0.00015813542269198152,0,0,35
3,"GPCRs, Class A Rhodopsin-like WP455",3.0114501301338046e-05,2.859725774367718,29.771185844879255,"['GPR27', 'CHRM1', 'GPR87', 'CHRM5', 'HTR2B', 'OPRL1', 'GPR83', 'ADRA1D', 'MCHR1', 'LTB4R', 'GPR171', 'DRD1', 'P2RY12', 'GPR39', 'GPR12', 'P2RY14', 'SSTR1', 'GPR6', 'ADRA2C', 'HTR5A', 'SSTR3', 'HCRTR2', 'MAS1', 'ADORA2A', 'LPAR6', 'FSHR', 'ACKR4', 'RGL4']",0.0053403048974372804,0,0,28
4,Glycolysis and Gluconeogenesis WP534,5.172538495644951e-05,4.685900040633888,46.247780470728884,"['TPI1', 'MDH2', 'PGAM1', 'GOT2', 'SLC2A3', 'ENO1', 'ENO2', 'LDHB', 'LDHA', 'PFKL', 'PKM', 'PGK1', 'ALDOC', 'ALDOA', 'GAPDH']",0.0068794761992077855,0,0,15
5,Mitochondrial complex III assembly WP4921,0.00029460343905045,7.017227401702472,57.049219377745494,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRC1', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.031345805914967884,0,0,9
6,VEGFA-VEGFR2 Signaling Pathway WP3888,0.00044327605289779773,1.5403713692189949,11.893696929916283,"['YWHAE', 'ARPC5L', 'HSPB1', 'SHB', 'RPL10A', 'ELK1', 'RPL7', 'HERPUD1', 'ACTG1', 'RND1', 'TUBB8', 'RPL18A', 'TMSB4X', 'CFL1', 'BSG', 'RACK1', 'RPLP2', 'SH3BGRL3', 'CHAC1', 'RAC1', 'ATP6V1E1', 'RPS11', 'IER5', 'TMSB10', 'HRAS', 'DUSP5', 'HSP90AA1', 'SSR4', 'PDPK1', 'IGFBP3', 'PRKCD', 'RPL13A', 'EPN1', 'VAV2', 'RCN1', 'RAB37', 'KATNAL2', 'NCL', 'FSCN1', 'RPL27', 'RPL26', 'TKT', 'PFN1', 'ATP6V0D1', 'ALDOA', 'GAPDH', 'SLC25A11', 'PTMA', 'FJX1', 'ARF6', 'NAPA', 'LRRC59', 'SET', 'CRIP2', 'FOXO4', 'ACACB', 'FUT1', 'PPP2CA', 'SCUBE2', 'PRDX2', 'STIP1', 'SDCBP', 'LDHA', 'DNAJB4', 'AP2S1', 'PGK1', 'DNAJB9', 'FADD', 'CCT7', 'ABCF2', 'MAPK3', 'EGR1', 'JUN', 'JAG1', 'SDF2L1', 'EGR3', 'FN1', 'NFATC2', 'DNAJA1', 'NFKBIA', 'NR4A1', 'NR4A3', 'NOX4', 'CYCS', 'HYOU1', 'P4HB', 'CALR', 'EIF4G2', 'HSPA1A', 'EIF4G1']",0.0316295629469226,0,0,90
7,Vitamin D Receptor Pathway WP2877,0.00048192572495710283,2.443517951856385,18.662907283464353,"['COLEC11', 'CEBPA', 'CDKN1A', 'ABCB1', 'CDKN1B', 'PRDM1', 'BGLAP', 'DND1', 'CREG2', 'TIMP2', 'SOSTDC1', 'JUNB', 'CDKN2D', 'G6PD', 'CDKN2C', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'NFATC2', 'CEACAM1', 'CDC34', 'TNFSF4', 'NINJ1', 'S100A6', 'PRKCQ']",0.0316295629469226,0,0,25
8,Metabolic reprogramming in colon cancer WP4290,0.0005256965908028029,3.258819370802404,24.606648774011862,"['G6PD', 'SHMT2', 'MDH2', 'PGAM1', 'GOT2', 'PDHB', 'ENO1', 'ACLY', 'LDHA', 'PFKL', 'PKM', 'FASN', 'PGK1', 'TKT', 'SLC16A3', 'GAPDH']",0.0316295629469226,0,0,16
9,Mitochondrial CIV Assembly WP4922,0.0005350865912073373,3.6421608448415923,27.43669619736456,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",0.0316295629469226,0,0,14
10,Computational Model of Aerobic Glycolysis WP4629,0.0009003413527785612,8.181551235317942,57.37506367555981,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ENO1', 'ALDOA', 'GAPDH']",0.04354378178892678,0,0,7
11,Glycolysis in senescence WP5049,0.0009003413527785612,8.181551235317942,57.37506367555981,"['LDHA', 'G6PD', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.04354378178892678,0,0,7
12,Proximal tubule transport WP4917,0.0011121745144833672,3.2773761169780666,22.29087098007384,"['ATP6V1G1', 'ATP6V0B', 'SLC22A6', 'SLC47A1', 'ABCB1', 'SLC3A1', 'ATP1B1', 'SLC5A8', 'CA4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.049306403475429285,0,0,14
13,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.0015531639928806037,2.400536486016591,15.525376445460498,"['PSMD10', 'HSPA8', 'HSPA5', 'TUBB', 'UBE2L6', 'TUBB4B', 'TUBB4A', 'TUBA4A', 'PSMD8', 'TUBB8', 'TUBA1B', 'TUBB6', 'PSMC5', 'TUBA1A', 'TUBB2A', 'PSMC3', 'TUBB3', 'PSMD2', 'STUB1', 'HSPA1B', 'HSPA1A']",0.06356024955480624,0,0,21
14,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.0017193258962260674,4.676935549250102,29.772543822412015,"['H3F3B', 'H2AFZ', 'H3F3A', 'H2AFX', 'PCGF1', 'H2AFV', 'DUSP6', 'MAPK3', 'EZH2']",0.06533438405659056,0,0,9
15,Oxidative phosphorylation WP623,0.0019480367841550675,2.5550706413196242,15.946025170514973,"['ATP5PF', 'NDUFB7', 'NDUFA11', 'ATP6AP1', 'NDUFB10', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFA2', 'NDUFC2', 'ATP5MC3', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS5', 'ATP5MF']",0.06909037127803307,0,0,18
16,Nonalcoholic fatty liver disease WP4396,0.0025390439614600578,1.8171337916446324,10.859132776270979,"['CEBPA', 'NDUFA13', 'COX7B', 'GSK3A', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'COX4I1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7C', 'UQCRH', 'BBC3', 'LEPR', 'UQCRFS1', 'CYC1', 'RAC1', 'COX8A', 'XBP1', 'JUN', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6B1', 'UQCRQ', 'NDUFS5', 'UQCRC1', 'CYCS']",0.08187398999752113,0,0,36
17,HIF1A and PPARG regulation of glycolysis WP2456,0.0026162741164621416,11.680493727235937,69.4522631984942,"['LDHA', 'TPI1', 'GPAT3', 'PPARG', 'GAPDH']",0.08187398999752113,0,0,5
18,Pathogenic Escherichia coli infection WP2272,0.0030364152212991814,2.7008251805082364,15.656893325299299,"['TUBB', 'ARPC5L', 'ARPC4', 'TUBB4B', 'TUBB4A', 'ACTB', 'TUBA4A', 'ACTG1', 'TUBB8', 'TUBA1B', 'TUBB6', 'TUBA1A', 'TUBB2A', 'TUBB3', 'NCL']",0.0875246302346918,0,0,15
19,Exercise-induced Circadian Regulation WP410,0.0031258796512389927,2.5832352116624615,14.900202860091936,"['DAZAP2', 'HSPA8', 'GSTM3', 'CEBPB', 'BTG1', 'RBPMS', 'GSTP1', 'GFRA1', 'TOB1', 'HERPUD1', 'PER2', 'DNAJA1', 'TUBB3', 'SUMO3', 'KLF9', 'EIF4G2']",0.0875246302346918,0,0,16
20,Cori Cycle WP1946,0.0033662231134865927,5.453422438234103,31.05159049994637,"['G6PD', 'LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.08954153481874337,0,0,7
21,Calcium Regulation in the Cardiac Cell WP536,0.003609593422008284,1.821511641906046,10.244473168153442,"['YWHAE', 'GNAZ', 'CHRM1', 'RGS14', 'YWHAB', 'CHRM5', 'ITPR2', 'ADRA1D', 'RGS4', 'GNG3', 'PLN', 'GJA9', 'YWHAG', 'YWHAH', 'PRKCG', 'PRKCH', 'PRKCD', 'ATP1B1', 'GNG13', 'CACNB1', 'GJD2', 'FKBP1A', 'SLC8A3', 'CACNB3', 'PRKAR1A', 'GNB2', 'GNAS', 'PRKCQ', 'CALM3', 'CALR', 'CASQ1', 'CALM1', 'CALM2']",0.0914430333575432,0,0,33
22,IL-18 signaling pathway WP4754,0.0053329486193958945,1.6002194787379973,8.37531029000918,"['MTCH1', 'BTG2', 'CEBPB', 'NRN1', 'STOML1', 'CD81', 'MEPCE', 'HSPB1', 'ENO1', 'PLD1', 'KLC1', 'RND2', 'ACACB', 'FUT1', 'CENPB', 'PTMS', 'TMSB4X', 'STMN1', 'BSG', 'FADD', 'RPS11', 'MAPK3', 'CA11', 'SLC12A3', 'JUN', 'USP5', 'IMP3', 'BAD', 'PRKCD', 'FN1', 'IL18', 'NDUFC1', 'TACR1', 'EEF2', 'RUNX2', 'NFKBIA', 'NR4A1', 'ARL4D', 'UCK1', 'NACA', 'CYCS', 'NFKBIE', 'CDK5R2', 'ITM2C', 'ARF6', 'MYH7']",0.1289603938872098,0,0,46
23,Myometrial relaxation and contraction pathways WP289,0.005917125553844701,1.7655916048907287,9.057316312629162,"['YWHAE', 'RGS14', 'YWHAB', 'ITPR2', 'RXFP1', 'ACTB', 'ACTG1', 'RGS4', 'GNG3', 'IGFBP6', 'YWHAG', 'CORIN', 'YWHAH', 'PRKCG', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP4', 'IGFBP3', 'PRKCD', 'GNG13', 'CREB3', 'CACNB3', 'ACTC1', 'PRKAR1A', 'GNB2', 'GNAS', 'PRKCQ', 'CALM3', 'ATF5', 'CALM1', 'CALM2']",0.1363652440725917,0,0,32
24,NRF2 pathway WP2884,0.006151815522071806,1.9205944713098033,9.77776188327857,"['HSP90AB1', 'SRXN1', 'GSTP1', 'KEAP1', 'SLC2A3', 'SLC5A3', 'SLC5A4', 'DNAJB1', 'FTH1', 'PRDX1', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'GSTM3', 'EGR1', 'G6PD', 'HSP90AA1', 'SLC6A16', 'GPX3', 'SLC2A12', 'NRG1', 'SLC2A9', 'SLC5A8', 'SLC6A8', 'HSPA1A']",0.1363652440725917,0,0,25
25,Selenium Micronutrient Network WP15,0.009909298436335914,2.202391200382592,10.1624534708694,"['GPX4', 'GPX3', 'KMO', 'SELENOK', 'SELENOH', 'SOD1', 'PRDX3', 'PRDX2', 'SELENOM', 'PRDX5', 'RFK', 'PRDX1', 'SELENOW', 'PNPO', 'SEPHS2', 'MSRB1']",0.2027594910819502,0,0,16
26,Translation Factors WP107,0.009909298436335914,2.202391200382592,10.1624534708694,"['EIF4A2', 'EIF5A', 'EIF1AX', 'EEF2', 'GSPT2', 'EIF1', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF6', 'EIF3I', 'EEF1A2', 'EIF4H', 'EIF3G', 'EIF4B', 'EIF4G1']",0.2027594910819502,0,0,16
27,Senescence and Autophagy in Cancer WP615,0.012076833418581226,1.8731866340668297,8.272865558789432,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'SPARC', 'CDKN1B', 'PCNA', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'FN1', 'HMGA1', 'BMI1', 'GABARAP', 'RSL1D1', 'MAP1LC3B', 'FKBP8', 'IL6ST', 'SLC39A1', 'HRAS', 'SLC39A3']",0.23795834735871155,0,0,22
28,miR-517 relationship with ARCN1 and USP1 WP3596,0.019086443010095495,14.006469874646179,55.44849059481134,"['CDKN1A', 'ID2', 'USP1']",0.3501375062541656,0,0,3
29,Nucleotide GPCRs WP80,0.019086443010095495,14.006469874646179,55.44849059481134,"['ADORA2A', 'LPAR6', 'LTB4R']",0.3501375062541656,0,0,3
30,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.02158652331387222,6.226537216828479,23.8830421271086,"['TPO', 'SPI1', 'ID2', 'RUNX2']",0.38280101343266737,0,0,4
31,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.02250149242264951,2.0047599698148257,7.606407436160406,"['FZD1', 'CDKN1A', 'JUN', 'CDKN1B', 'FN1', 'ELK1', 'SOD1', 'PPP2CA', 'TMSB4X', 'NEFL', 'PFN4', 'NEFM', 'PFN1', 'NEFH', 'PFN2']",0.38615464415643674,0,0,15
32,Nuclear Receptors Meta-Pathway WP2882,0.024585226732520987,1.435539250665301,5.319547964945667,"['ABCB1', 'CDKN1B', 'HSP90AB1', 'SRXN1', 'GSTP1', 'AMIGO2', 'KEAP1', 'SLC2A3', 'SLC5A3', 'SLC5A4', 'CYP3A7', 'PTPA', 'DNAJB1', 'FTH1', 'PRDX1', 'ENC1', 'SLC39A7', 'JUNB', 'SLC39A1', 'SLC39A3', 'EGR1', 'GSTM3', 'JUN', 'G6PD', 'HSP90AA1', 'JUND', 'GADD45B', 'SLC6A16', 'GPX3', 'PLK2', 'TSC22D3', 'SLC2A12', 'AIP', 'NRG1', 'SLC2A9', 'SLC7A5', 'SLC5A8', 'PSMC5', 'SLC6A8', 'FASN', 'B3GNT5', 'BHLHE40', 'AHRR', 'HSPA1A', 'FKBP5']",0.4087293944281614,0,0,45
33,Gastric acid production WP2596,0.03116538207375481,inf,inf,"['CCK', 'MUC6']",0.502423735249623,0,0,2
34,"GPCRs, Other WP117",0.034000156348941726,2.1425456389452333,7.244782732049314,"['GPR162', 'ADORA2A', 'FSHR', 'ADGRF5', 'GPR88', 'GNRHR', 'OR2M4', 'ADRA1D', 'GPR83', 'CELSR2', 'RXFP1']",0.5320024464010882,0,0,11
35,Synaptic Vesicle Pathway WP2267,0.03644157588577688,1.960735007137899,6.494042501194976,"['NAPA', 'RAB3A', 'PARK7', 'CPLX2', 'SYN1', 'STX1B', 'CLTCL1', 'AP2S1', 'SLC17A7', 'SLC25A4', 'SLC18A2', 'AP2M1', 'VAMP2']",0.5511368091467486,0,0,13
36,Monoamine GPCRs WP58,0.037294972047524334,2.7252936411502633,8.963209423898332,"['CHRM1', 'CHRM5', 'HTR2B', 'ADRA1D', 'DRD1', 'HTR5A', 'ADRA2C']",0.5511368091467486,0,0,7
37,Pathways in clear cell renal cell carcinoma WP4018,0.041382310658918064,1.6770413374186959,5.341211920940527,"['TPI1', 'SHMT2', 'BHLHE41', 'PLOD2', 'ENO1', 'ENO2', 'ACACB', 'ACLY', 'LDHB', 'LDHA', 'PFKL', 'PKM', 'FASN', 'PGK1', 'ALDOC', 'ALDOA', 'GAPDH', 'KCNJ2', 'BAP1']",0.5950105208255246,0,0,19
38,Galanin receptor pathway WP4970,0.045383438539318505,3.335838584725675,10.316441195139722,"['CDKN1A', 'CDKN1B', 'PRKCD', 'PPARG', 'VAMP2']",0.6210743041769236,0,0,5
39,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.04557151299306224,1.5211326530612246,4.6979763263685745,"['YWHAE', 'CEBPB', 'YWHAB', 'MAZ', 'ATP1A3', 'HSP90B1', 'NEUROD1', 'TPPP', 'SCN3B', 'YWHAG', 'YWHAH', 'CHRNB2', 'EGR1', 'JUN', 'TSPYL1', 'SSTR1', 'TACR1', 'ADCYAP1', 'AR', 'PRKAR1A', 'KCNQ1', 'BHLHE40', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2']",0.6210743041769236,0,0,26
40,Aryl Hydrocarbon Receptor Pathway WP2873,0.047864749006116286,2.336102106969206,7.1002926176323005,"['SLC7A5', 'HSP90AA1', 'JUN', 'CDKN1B', 'JUND', 'AIP', 'AHRR', 'JUNB']",0.6210743041769236,0,0,8
41,Peptide GPCRs WP24,0.047864749006116286,2.336102106969206,7.1002926176323005,"['FSHR', 'GNRHR', 'OPRL1', 'TAC4', 'SSTR1', 'TACR1', 'SSTR3', 'HCRTR2']",0.6210743041769236,0,0,8
42,Spinal Cord Injury WP2431,0.05985364469142274,1.586785568928426,4.468154828033663,"['RTN4R', 'EGR1', 'BTG2', 'CDKN1B', 'XYLT1', 'MIF', 'TACR1', 'NTN1', 'RTN4', 'LTB4R', 'TNFSF13B', 'RHOB', 'SELP', 'FKBP1A', 'NR4A1', 'ACAN', 'NOX4', 'RAC1', 'MAPK3']",0.7410006802729903,0,0,19
43,Apoptosis Modulation and Signaling WP1772,0.06323623440090226,1.6222456449029388,4.478822008234575,"['DAXX', 'JUN', 'ENDOG', 'CRADD', 'CDKN2A', 'BAD', 'BNIP3', 'BBC3', 'NFKBIA', 'CAPNS1', 'TOLLIP', 'PEA15', 'CYCS', 'FADD', 'BCL2L2', 'MAPK3', 'HSPA1A']",0.7410006802729903,0,0,17
44,Nicotine Activity on Dopaminergic Neurons WP1602,0.06332192865743773,2.918605827600162,8.053961618142342,"['CHRNB2', 'CDK5', 'PPP1R1B', 'SLC18A2', 'KCNK3']",0.7410006802729903,0,0,5
45,NO/cGMP/PKG mediated Neuroprotection WP4008,0.06397414190739918,1.9469789132197892,5.352783002111807,"['NFKBIA', 'BAD', 'DLG4', 'PDE3A', 'NEFL', 'CYCS', 'CALM1', 'CALM2', 'GRIN2D', 'CNGB1']",0.7410006802729903,0,0,10
46,Purinergic signaling WP4900,0.06407148739202548,2.5475156422524843,6.999950954173297,"['P2RY12', 'GNAZ', 'ADORA2A', 'LPAR6', 'P2RY14', 'GNAS']",0.7410006802729903,0,0,6
47,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.06876353816336857,2.002316289304534,5.360364181740234,"['PRKCG', 'PRKCH', 'FSHR', 'PRKCD', 'PRKCQ', 'AMH', 'HRAS', 'PLCB2', 'MAPK3']",0.7783447298491932,0,0,9
48,Alzheimer's disease WP2059,0.08014545158084423,1.5583570557137048,3.933156307534117,"['PSENEN', 'ATP5MD', 'BAD', 'ITPR2', 'LPL', 'ATP2A1', 'GRIN2D', 'CDK5', 'CYCS', 'CALM3', 'FADD', 'CALM1', 'PLCB2', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.8882787550210236,0,0,17
49,Transcriptional cascade regulating adipogenesis WP4211,0.08323767940038779,3.1124595469255665,7.737746105298942,"['CEBPA', 'CEBPB', 'EGR2', 'PPARG']",0.9037233763470675,0,0,4
50,Circadian rhythm related genes WP3594,0.08652208488489702,1.3428108704550712,3.2863356780942765,"['AHCY', 'CHRM1', 'CIPC', 'BHLHE41', 'OPRL1', 'RELB', 'PPP1CC', 'DBP', 'UBC', 'DRD1', 'RPS27A', 'SKP1', 'PRKCG', 'CHRNB2', 'KLF10', 'EGR1', 'JUN', 'EGR3', 'JUND', 'NR1D1', 'CARTPT', 'HCRTR2', 'NR2F6', 'PER2', 'ADORA2A', 'ID2', 'BHLHE40', 'KLF9', 'PPARG', 'GHRL', 'ATF5', 'UBA52', 'EZH2']",0.91318042787616,0,0,33
51,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.08908954172579914,1.9667320651710314,4.75578101980686,"['NFKBIA', 'NDUFA13', 'HSP90AA1', 'IL18', 'PRDM1', 'RAC1', 'NLRP1', 'AAMP']",0.91318042787616,0,0,8
52,Complement system WP2806,0.08925823731120362,1.7968993698920706,4.341707012659721,"['SELP', 'PRNP', 'FKBP2', 'RPS19', 'C1QBP', 'F12', 'SERPING1', 'CD59', 'CALR', 'C2']",0.91318042787616,0,0,10
53,7q11.23 copy number variation syndrome WP4932,0.0941161459267252,1.4439858631843776,3.41246445100373,"['PCNA', 'H2AFX', 'HMGA1', 'ATP5MC3', 'VPS37D', 'UBE2L6', 'NRG1', 'ACACB', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'GRIP1', 'ATP5F1B', 'CFL1', 'BCL7B', 'NUP62', 'EIF4H', 'WNT2', 'GAPDH', 'VAMP2', 'MAPK3']",0.9345619534968228,0,0,21
54,Sleep regulation WP3591,0.09608605582029586,2.043261441879303,4.786362555209391,"['CHRNB2', 'AHCY', 'ADORA2A', 'IL18', 'GHRL', 'DRD1', 'HCRTR2']",0.9345619534968228,0,0,7
55,16p11.2 proximal deletion syndrome WP4949,0.09814010634011172,1.5261987721918036,3.5428555070816357,"['PCNA', 'PRRT2', 'DOC2A', 'IGFBP3', 'MAZ', 'SEZ6L2', 'PPP2CA', 'PPP2R1A', 'TCP1', 'TMEM219', 'PPARG', 'ALDOA', 'CCT7', 'CDIPT', 'YPEL3', 'MAPK3']",0.9345619534968228,0,0,16
56,Ovarian infertility WP34,0.10303593450863581,2.155216443475553,4.898111860250012,"['EGR1', 'CEBPB', 'CDKN1B', 'SMPD1', 'FSHR', 'MSH5']",0.9345619534968228,0,0,6
57,Cell cycle WP179,0.10356923566277307,1.4090944613770082,3.195142751946393,"['YWHAE', 'CDKN2D', 'ANAPC13', 'CDKN1A', 'CDKN1B', 'PCNA', 'CDKN2C', 'GADD45B', 'YWHAB', 'CDKN2A', 'ANAPC11', 'SMC1B', 'MAD2L2', 'CCNA1', 'PTTG1', 'TFDP2', 'MCM3', 'MCM4', 'BUB3', 'YWHAG', 'SKP1', 'YWHAH']",0.9345619534968228,0,0,22
58,Common Pathways Underlying Drug Addiction WP2636,0.10385902498185372,1.7301973506353068,3.9184139772642594,"['PRKCG', 'PPP1CC', 'PPP1R1A', 'GNAS', 'DRD1', 'CALM1', 'CALM2', 'ACTB', 'ACTG1', 'MAPK3']",0.9345619534968228,0,0,10
59,Kynurenine Pathway and links to Cellular Senescence WP5044,0.10927060339968937,2.3344799676244437,5.168370270022418,"['CDKN1A', 'TDO2', 'HAAO', 'KMO', 'ACMSD']",0.9345619534968228,0,0,5
60,NAD Biosynthesis II (from tryptophan) WP2485,0.11014033837937243,3.500707642539426,7.722560789490381,"['TDO2', 'HAAO', 'KMO']",0.9345619534968228,0,0,3
61,Sulfation Biotransformation Reaction WP692,0.11014033837937243,3.500707642539426,7.722560789490381,"['G6PD', 'SULT4A1', 'PAPSS2']",0.9345619534968228,0,0,3
62,Hypertrophy Model WP516,0.11316566410420445,2.6675913083680074,5.812421317051495,"['JUND', 'NR4A3', 'WDR1', 'IL18']",0.9345619534968228,0,0,4
63,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.11316566410420445,2.6675913083680074,5.812421317051495,"['PTTG1', 'BUB3', 'ANAPC11', 'MAD2L1']",0.9345619534968228,0,0,4
64,Cell migration and invasion through p75NTR WP4561,0.11594189648644794,1.9229028184785457,4.143213527573916,"['EFNA1', 'EFNB1', 'ARF1', 'JUN', 'EFNA3', 'EFNB3', 'RAC1']",0.9345619534968228,0,0,7
65,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.11594189648644794,1.9229028184785457,4.143213527573916,"['RAB3B', 'EGR2', 'RAB3A', 'HSPB1', 'NEFL', 'RABAC1', 'RAB11B']",0.9345619534968228,0,0,7
66,Photodynamic therapy-induced unfolded protein response WP3613,0.11594189648644794,1.9229028184785457,4.143213527573916,"['PPP1R15A', 'XBP1', 'HSPA5', 'DNAJB9', 'CALR', 'HSP90B1', 'BBC3']",0.9345619534968228,0,0,7
67,Complement and Coagulation Cascades WP558,0.1262412469339073,2.001098901098901,4.141395331250062,"['SERPIND1', 'F12', 'SERPING1', 'CLU', 'F5', 'C2']",0.9999897633382736,0,0,6
68,Proteoglycan biosynthesis WP4784,0.13690717134487926,2.1220705639969095,4.219635805650275,"['CANT1', 'B3GAT3', 'XYLT1', 'B3GALT6', 'PAPSS2']",0.9999897633382736,0,0,5
69,G1 to S cell cycle control WP45,0.14310992427434904,1.515005265005265,2.9453857337648803,"['CDKN2D', 'CCNA1', 'CREB3', 'CDKN1A', 'CDKN1B', 'PCNA', 'CDKN2C', 'TFDP2', 'CDKN2A', 'CCNG2', 'MCM3', 'MCM4']",0.9999897633382736,0,0,12
70,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.14573718539329011,1.6980993074996316,3.2704550056172628,"['LDHA', 'PFKL', 'ANGPT2', 'PKM', 'IGFBP3', 'BNIP3', 'PGK1', 'SLC2A3']",0.9999897633382736,0,0,8
71,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.14590973736482735,4.6665319320937755,8.981987067208221,"['ATP4A', 'CHRM1']",0.9999897633382736,0,0,2
72,Vitamin B6-dependent and responsive disorders WP4228,0.14590973736482735,4.6665319320937755,8.981987067208221,"['PNPO', 'AASS']",0.9999897633382736,0,0,2
73,Androgen receptor signaling pathway WP138,0.1469999787447229,1.3788899411756859,2.6437771736459976,"['CDKN1A', 'DAXX', 'JUN', 'RNF6', 'PARK7', 'ETV5', 'RUNX2', 'RHOB', 'AR', 'PRDX1', 'BAG1', 'RACK1', 'PAK6', 'STUB1', 'RAC1', 'CALR', 'FKBP4', 'RAN']",0.9999897633382736,0,0,18
74,Cell Differentiation - Index expanded WP2023,0.14705679074127181,2.333940129449838,4.47401487180404,"['ID2', 'MEF2D', 'RUNX2', 'EZH2']",0.9999897633382736,0,0,4
75,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.14705679074127181,2.333940129449838,4.47401487180404,"['CD63', 'CD81', 'HSPB1', 'SOD1']",0.9999897633382736,0,0,4
76,Ganglio Sphingolipid Metabolism WP1423,0.14705679074127181,2.333940129449838,4.47401487180404,"['B3GALT1', 'B4GALNT1', 'FUT1', 'ST6GALNAC6']",0.9999897633382736,0,0,4
77,White fat cell differentiation WP4149,0.1517240661201705,1.8675303643724697,3.521586624056664,"['CEBPA', 'CEBPB', 'EGR2', 'IRF3', 'PPARG', 'ZNF423']",0.9999897633382736,0,0,6
78,Blood Clotting Cascade WP272,0.15389794100375392,2.800323493732309,5.24070913505284,"['F8A1', 'F12', 'F5']",0.9999897633382736,0,0,3
79,Mitochondrial complex I assembly model OXPHOS system WP4324,0.15974926103959725,1.4750085440874914,2.7053866430479445,"['NDUFA13', 'NDUFB7', 'NDUFB10', 'NDUFB11', 'NDUFS5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFAF3', 'NDUFC1', 'TMEM70']",0.9999897633382736,0,0,12
80,Nuclear receptors WP170,0.16137749138671514,1.720193558014112,3.1376485168384787,"['NR4A1', 'AR', 'THRA', 'ESRRB', 'NR2F1', 'PPARG', 'NR2F6']",0.9999897633382736,0,0,7
81,Zinc homeostasis WP3529,0.16137749138671514,1.720193558014112,3.1376485168384787,"['MT2A', 'SLC30A1', 'SLC39A7', 'SLC30A10', 'SLC39A1', 'MT3', 'SLC39A3']",0.9999897633382736,0,0,7
82,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.16725538096814754,1.9450627276406314,3.478226148839,"['EIF5', 'EIF1AX', 'EIF3I', 'EIF3G', 'EIF1']",0.9999897633382736,0,0,5
83,CAMKK2  Pathway WP4874,0.16778850003984694,1.6241279684306955,2.8991512883291612,"['FIS1', 'WFS1', 'NFATC2', 'RAC1', 'CALM1', 'CALM2', 'GIT1', 'MAPK3']",0.9999897633382736,0,0,8
84,Glycogen Synthesis and Degradation WP500,0.17203950264820267,1.5565464126469395,2.739570191324759,"['PPP2CA', 'PTPA', 'GSK3A', 'PPP2R1A', 'PHKA1', 'CALM3', 'GYG2', 'CALM1', 'CALM2']",0.9999897633382736,0,0,9
85,Corticotropin-releasing hormone signaling pathway WP2355,0.1760017310330043,1.3589948263118994,2.360929320568014,"['GNAZ', 'HSP90AA1', 'JUND', 'PRKCD', 'IL18', 'ELK1', 'FOSL2', 'NFKBIA', 'NR4A1', 'TRIM28', 'GNB2', 'GNAS', 'FOSB', 'PRKCQ', 'JUNB', 'MAPK3']",0.9999897633382736,0,0,16
86,Adipogenesis WP236,0.18412787803547392,1.297842019543974,2.1961106332858678,"['FZD1', 'GDF10', 'CEBPA', 'EGR2', 'CDKN1A', 'CEBPB', 'GADD45B', 'HMGA1', 'NR2F1', 'LPL', 'MIF', 'BSCL2', 'SFRP4', 'BMP3', 'CYP26B1', 'PNPLA3', 'NDN', 'PPARG', 'IL6ST', 'MEF2D']",0.9999897633382736,0,0,20
87,Globo Sphingolipid Metabolism WP1424,0.1999399081073662,1.7952868661083958,2.8899422379896746,"['FUT2', 'ST6GALNAC3', 'FUT1', 'ABO', 'ST6GALNAC6']",0.9999897633382736,0,0,5
88,Genes targeted by miRNAs in adipocytes WP1992,0.20194649718579702,2.333400727860898,3.7328636060846594,"['TMSB4X', 'KCNQ1', 'KCNJ2']",0.9999897633382736,0,0,3
89,Glutathione metabolism WP100,0.20194649718579702,2.333400727860898,3.7328636060846594,"['G6PD', 'GPX4', 'GPX3']",0.9999897633382736,0,0,3
90,Matrix Metalloproteinases WP129,0.20194649718579702,2.333400727860898,3.7328636060846594,"['MMP15', 'BSG', 'TIMP2']",0.9999897633382736,0,0,3
91,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.20194649718579702,2.333400727860898,3.7328636060846594,"['JUN', 'PRKCQ', 'MAPK3']",0.9999897633382736,0,0,3
92,Thiamine metabolic pathways WP4297,0.20194649718579702,2.333400727860898,3.7328636060846594,"['BCKDK', 'SLC19A3', 'TKT']",0.9999897633382736,0,0,3
93,16p11.2 distal deletion syndrome WP4950,0.20862937977373472,1.6475351274112884,2.582010302876717,"['PLN', 'CD81', 'NFATC2', 'ATP2A1', 'TUFM', 'VAV2']",0.9999897633382736,0,0,6
94,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.21553790828367525,3.110751818916734,4.773817216802936,"['COX8A', 'GSTP1']",0.9999897633382736,0,0,2
95,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.21553790828367525,3.110751818916734,4.773817216802936,"['PPARG', 'CYP2C18']",0.9999897633382736,0,0,2
96,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.21553790828367525,3.110751818916734,4.773817216802936,"['CDKN1A', 'ABCB1']",0.9999897633382736,0,0,2
97,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.21626216075321578,1.3881914368729784,2.125687433648111,"['PRKCG', 'IFI27L2', 'JUN', 'PRKCH', 'PRKCD', 'PRKCQ', 'ISG15', 'HRAS', 'PLCB2', 'RELB', 'MAPK3']",0.9999897633382736,0,0,11
98,Modulators of TCR signaling and T cell activation WP5072,0.21697533134104433,1.414878714148787,2.1618945101514933,"['NFKBIA', 'FIBP', 'CDKN1B', 'NDUFB10', 'PDPK1', 'ELOB', 'MAP3K8', 'PRKCQ', 'RNF7', 'MEF2D']",0.9999897633382736,0,0,10
99,Differentiation of white and brown adipocyte WP2895,0.22411599964846246,1.8668284789644014,2.7920128155411112,"['CEBPA', 'CEBPB', 'PPARG', 'ZNF423']",0.9999897633382736,0,0,4
100,Imatinib and Chronic Myeloid Leukemia WP3640,0.22411599964846246,1.8668284789644014,2.7920128155411112,"['SPRED2', 'ABCB1', 'CDKN1B', 'PIM2']",0.9999897633382736,0,0,4
101,Gastrin signaling pathway WP4659,0.23035195117876228,1.2499154470985456,1.8350595103434544,"['CHGA', 'EGR1', 'JUN', 'CDKN1A', 'PRKCH', 'JAG1', 'CDKN1B', 'CDKN2A', 'BAD', 'PRKCD', 'ELK1', 'RHOB', 'NFKBIA', 'PRKCQ', 'PPARG', 'RAC1', 'HRAS', 'MEF2D', 'MAPK3']",0.9999897633382736,0,0,19
102,Gastric Cancer Network 1 WP2361,0.23454847171527954,1.6669075562236226,2.41717099567145,"['CCNA1', 'H3F3A', 'MCM4', 'GATD3B', 'GATD3A']",0.9999897633382736,0,0,5
103,Glucocorticoid Receptor Pathway WP2880,0.23946481942093398,1.3731453652020418,1.962703631493329,"['HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'TSC22D3', 'B3GNT5', 'PLK2', 'ENC1', 'AMIGO2', 'BHLHE40']",0.9999897633382736,0,0,10
104,Development and heterogeneity of the ILC family WP3893,0.2528217069569574,1.9998844665241753,2.749982641833284,"['IL7', 'ID2', 'IL18']",0.9999897633382736,0,0,3
105,Dopamine metabolism WP2436,0.2528217069569574,1.9998844665241753,2.749982641833284,"['PPP2CA', 'TYR', 'SOD1']",0.9999897633382736,0,0,3
106,Dopaminergic Neurogenesis WP2855,0.2528217069569574,1.9998844665241753,2.749982641833284,"['NEUROD1', 'ALDH1A1', 'SLC18A2']",0.9999897633382736,0,0,3
107,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.2528217069569574,1.9998844665241753,2.749982641833284,"['GRM2', 'GABBR1', 'GRM4']",0.9999897633382736,0,0,3
108,Proteasome Degradation WP183,0.2558003818277065,1.302929628511024,1.7763593984714792,"['PSMD8', 'PSMD10', 'PSMB6', 'PSMC5', 'UBB', 'PSMC3', 'H2AFZ', 'PSMB3', 'PSMD2', 'H2AFX', 'UBC', 'PSME1']",0.9999897633382736,0,0,12
109,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.26589930690257385,1.3552309844789936,1.7951899015766764,"['NFKBIA', 'JUN', 'AHSA1', 'NFATC2', 'MAP3K8', 'PRKCQ', 'CALM1', 'CALM2', 'MAPK3']",0.9999897633382736,0,0,9
110,IL-6 signaling pathway WP364,0.2686400945673757,1.3830361966504592,1.8178388968630523,"['BAD', 'PRKCD', 'PRDM1', 'RAC1', 'IL6ST', 'JUNB', 'MAPK3', 'NR2F6']",0.9999897633382736,0,0,8
111,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.27065087845252506,1.555645487656819,2.0331128501645024,"['G6PD', 'MDH2', 'SCO2', 'GOT2', 'HMGA1']",0.9999897633382736,0,0,5
112,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.27065087845252506,1.555645487656819,2.0331128501645024,"['NFKBIA', 'GSK3A', 'NFATC2', 'CALM1', 'CALM2']",0.9999897633382736,0,0,5
113,Tryptophan metabolism WP465,0.2716656731231799,1.4738546771787768,1.9207025242982725,"['TDO2', 'HAAO', 'ALDH1A1', 'DHCR24', 'CYP2C18', 'ACMSD']",0.9999897633382736,0,0,6
114,ACE Inhibitor Pathway WP554,0.2872125175606547,2.3328617623282133,2.910321701528417,"['MAS1', 'ATP6AP2']",0.9999897633382736,0,0,2
115,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.2872125175606547,2.3328617623282133,2.910321701528417,"['HSD11B1', 'HSD11B2']",0.9999897633382736,0,0,2
116,Drug Induction of Bile Acid Pathway WP2289,0.2872125175606547,2.3328617623282133,2.910321701528417,"['ABCB1', 'SLC51A']",0.9999897633382736,0,0,2
117,EDA signaling in hair follicle development WP3930,0.2872125175606547,2.3328617623282133,2.910321701528417,"['SOSTDC1', 'RELB']",0.9999897633382736,0,0,2
118,Cytosolic DNA-sensing pathway WP4655,0.29152460005495295,1.3127660113498176,1.618155931002371,"['NFKBIA', 'IRF3', 'IL18', 'POLR2E', 'ISG15', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999897633382736,0,0,9
119,Oxidative Damage WP3941,0.30073210354981045,1.3612292426083434,1.6355651660231176,"['CDKN1A', 'PCNA', 'CDKN1B', 'BAD', 'CYCS', 'NFKBIE', 'C2']",0.9999897633382736,0,0,7
120,Development of ureteric collection system WP5053,0.30475212372570737,1.4000404858299595,1.6636072662092847,"['GRIP1', 'FRAS1', 'ITGA8', 'GFRA1', 'FAT4', 'ETV4']",0.9999897633382736,0,0,6
121,The influence of laminopathies on Wnt signaling WP4844,0.30475212372570737,1.4000404858299595,1.6636072662092847,"['CEBPA', 'CEBPB', 'ICMT', 'PPARG', 'EMD', 'RUNX2']",0.9999897633382736,0,0,6
122,RalA downstream regulated genes WP2290,0.3051927177761684,1.7497472705216337,2.0766207782821398,"['EXOC8', 'RAC1', 'HRAS']",0.9999897633382736,0,0,3
123,Pregnane X receptor pathway WP2876,0.3088682193806121,1.5554207119741101,1.8273713520298742,"['HSP90AA1', 'PSMC5', 'ABCB1', 'CYP3A7']",0.9999897633382736,0,0,4
124,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.317744644877257,1.2728746729557432,1.4593600056425913,"['CEBPA', 'CDKN1A', 'CEBPB', 'ICMT', 'PPARG', 'JUNB', 'EMD', 'ACTB', 'RUNX2']",0.9999897633382736,0,0,9
125,COVID-19 adverse outcome pathway WP4891,0.321968185607371,4.665050505050505,5.286913590243532,['IL7'],0.9999897633382736,0,0,1
126,Nanomaterial-induced inflammasome activation WP3890,0.321968185607371,4.665050505050505,5.286913590243532,['CTSB'],0.9999897633382736,0,0,1
127,Thyroxine (Thyroid Hormone) Production WP1981,0.321968185607371,4.665050505050505,5.286913590243532,['TPO'],0.9999897633382736,0,0,1
128,G13 Signaling Pathway WP524,0.33138780303195264,1.3066666666666666,1.4431688792743038,"['CFL2', 'CFL1', 'ARHGDIG', 'RAC1', 'PFN1', 'CALM1', 'CALM2']",0.9999897633382736,0,0,7
129,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.33138780303195264,1.3066666666666666,1.4431688792743038,"['NFKBIA', 'JUN', 'TNFSF12', 'FADD', 'RAC1', 'RELB', 'MAPK3']",0.9999897633382736,0,0,7
130,Vitamin D-sensitive calcium signaling in depression WP4698,0.33138780303195264,1.3066666666666666,1.4431688792743038,"['G6PD', 'CHRM1', 'CALB1', 'GPX4', 'KCNQ3', 'ITPR2', 'GRIN2D']",0.9999897633382736,0,0,7
131,Genotoxicity pathway WP4286,0.3362661447474119,1.2281768899133478,1.3385314513879571,"['PLK3', 'BTG2', 'CDKN1A', 'RPS27', 'EI24', 'ID2', 'PCDH8', 'TRIAP1', 'TRIM22', 'PHLDA3']",0.9999897633382736,0,0,10
132,Prostaglandin Synthesis and Regulation WP98,0.33848750229357144,1.3332562174667437,1.4442739403845153,"['HSD11B1', 'HSD11B2', 'S100A6', 'MITF', 'PPARG', 'PTGES']",0.9999897633382736,0,0,6
133,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.33848750229357144,1.3332562174667437,1.4442739403845153,"['CREB3', 'ITPR2', 'CALM3', 'CALM1', 'PLCB2', 'CALM2']",0.9999897633382736,0,0,6
134,Physiological and pathological hypertrophy of the heart WP1528,0.34562292286525764,1.372390315899731,1.458036963772417,"['JUN', 'RAC1', 'IL6ST', 'CALM1', 'CALM2']",0.9999897633382736,0,0,5
135,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.35244139134883234,1.435648493900921,1.4971960889324398,"['ANGPT2', 'LTBP1', 'RUNX2', 'MAPK3']",0.9999897633382736,0,0,4
136,G Protein Signaling Pathways WP35,0.3530170208244992,1.1489180737961227,1.1962983126502162,"['PRKCG', 'GNAZ', 'PRKCH', 'PRKCD', 'AKAP5', 'GNG13', 'GNG10', 'GNG3', 'PRKD3', 'PRKAR1A', 'GNB2', 'GNAS', 'PRKCQ', 'CALM1', 'HRAS', 'CALM2']",0.9999897633382736,0,0,16
137,PDGF Pathway WP2526,0.35311659698616216,1.2444084278768233,1.2953756308929278,"['NFKBIA', 'JUN', 'ARFIP2', 'RAC1', 'ELK1', 'HRAS', 'MAPK3', 'VAV2']",0.9999897633382736,0,0,8
138,Airway smooth muscle cell contraction WP4962,0.3579046820004201,1.5551961180752123,1.5979462500932065,"['GDI1', 'CALM1', 'CALM2']",0.9999897633382736,0,0,3
139,Cancer immunotherapy by PD-1 blockade WP4585,0.3579046820004201,1.5551961180752123,1.5979462500932065,"['JUN', 'NFATC2', 'PDCD1LG2']",0.9999897633382736,0,0,3
140,Major receptors targeted by epinephrine and norepinephrine WP4589,0.3579046820004201,1.5551961180752123,1.5979462500932065,"['ADCY10', 'ADRA1D', 'ADRA2C']",0.9999897633382736,0,0,3
141,miRNAs involved in DNA damage response WP1545,0.3579046820004201,1.5551961180752123,1.5979462500932065,"['CDKN1A', 'CDKN1B', 'H2AFX']",0.9999897633382736,0,0,3
142,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.3579046820004201,1.5551961180752123,1.5979462500932065,"['FZD1', 'SFRP4', 'DKK3']",0.9999897633382736,0,0,3
143,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.3579046820004201,1.5551961180752123,1.5979462500932065,"['FN1', 'RUNX2', 'MAPK3']",0.9999897633382736,0,0,3
144,Dual hijack model of Vif in HIV infection WP3300,0.35804137397117175,1.866127728375101,1.9167123479341057,"['UBB', 'ELOB']",0.9999897633382736,0,0,2
145,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.35804137397117175,1.866127728375101,1.9167123479341057,"['AHCY', 'MAT2B']",0.9999897633382736,0,0,2
146,Pentose Phosphate Metabolism WP134,0.35804137397117175,1.866127728375101,1.9167123479341057,"['G6PD', 'TKT']",0.9999897633382736,0,0,2
147,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.35804137397117175,1.866127728375101,1.9167123479341057,"['ELK1', 'MEF2D']",0.9999897633382736,0,0,2
148,Amyotrophic lateral sclerosis (ALS) WP2447,0.3624596444821401,1.2563012119512726,1.2749474059626962,"['DAXX', 'BAD', 'NEFL', 'NEFM', 'RAC1', 'NEFH', 'SOD1']",0.9999897633382736,0,0,7
149,Melanoma WP4685,0.36693419563496044,1.1667004870129871,1.169702116217512,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'MITF', 'CALM3', 'RAC1', 'CALM1', 'ELK1', 'HRAS', 'CALM2', 'MAPK3']",0.9999897633382736,0,0,12
150,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.36802589814607445,1.1009176077534777,1.100479407197876,"['SHC4', 'RAB3A', 'ELK1', 'ACACB', 'PPP2CA', 'GRIP1', 'CFL1', 'RACK1', 'RAC1', 'HRAS', 'MAPK3', 'VAV3', 'EGR1', 'JUN', 'EGR2', 'PDPK1', 'BAD', 'PRKCD', 'EEF2', 'SYN1', 'VAV2', 'NFKBIA', 'MARCKS', 'CDK5', 'CDK5R1']",0.9999897633382736,0,0,25
151,Prion disease pathway WP3995,0.3725833402502205,1.2725432462274568,1.2563749912426982,"['PRNP', 'SPI1', 'HSPA5', 'ELK1', 'HSP90B1', 'MAPK3']",0.9999897633382736,0,0,6
152,22q11.2 copy number variation syndrome WP4657,0.372695304608887,1.131411677753141,1.1166966176768158,"['RTN4R', 'RTL10', 'OAT', 'SERPIND1', 'ESS2', 'RTN4', 'SLC7A4', 'CYP26B1', 'MRPL40', 'ACTC1', 'THAP7', 'CLTCL1', 'DGCR6L', 'HIST1H4C', 'RAN', 'FGF10']",0.9999897633382736,0,0,16
153,Oncostatin M Signaling Pathway WP2374,0.37667594701771745,1.166632860040568,1.1390653467289744,"['NFKBIA', 'EGR1', 'CEBPB', 'CDKN1B', 'PRKCH', 'JUND', 'PRKCD', 'IL6ST', 'JUNB', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,11
154,Hematopoietic Stem Cell Differentiation WP2849,0.3836766748590308,1.2960339943342776,1.2415423404615074,"['TPO', 'SPI1', 'NFATC2', 'FOSB', 'ABO']",0.9999897633382736,0,0,5
155,Heart Development WP1591,0.3960132310893486,1.3329865926953306,1.2347556867509248,"['HEY1', 'BHLHE40', 'NFATC2', 'FGF10']",0.9999897633382736,0,0,4
156,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.3960132310893486,1.3329865926953306,1.2347556867509248,"['JUN', 'SRXN1', 'GSTP1', 'KEAP1']",0.9999897633382736,0,0,4
157,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3960132310893486,1.3329865926953306,1.2347556867509248,"['HTR2B', 'ELK1', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,4
158,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.3960132310893486,1.3329865926953306,1.2347556867509248,"['EGR1', 'GNAS', 'ELK1', 'MAPK3']",0.9999897633382736,0,0,4
159,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.3985713431057752,1.1664977705715445,1.0730248666844715,"['VAV3', 'BEX3', 'CDKN1A', 'CDKN1B', 'JUND', 'HSPA5', 'HSPB1', 'NRG1', 'RNF7']",0.9999897633382736,0,0,9
160,Metapathway biotransformation Phase I and II WP702,0.40236970934577865,1.1018198454656365,1.003079089898692,"['GSTM3', 'CHST9', 'GLYATL2', 'GPX4', 'GPX3', 'GSTP1', 'GLYAT', 'CYP2C18', 'NAT14', 'CYP3A7', 'CYP39A1', 'CYP26B1', 'CHST1', 'NAT8L', 'SULT4A1', 'GAL3ST3', 'CHST2']",0.9999897633382736,0,0,17
161,TNF-alpha signaling pathway WP231,0.4025068924126797,1.111046612875138,1.0111002574541663,"['HSP90AA1', 'JUN', 'BAD', 'PPP2CA', 'NFKBIA', 'SMPD2', 'PSMD2', 'RFK', 'MAP3K8', 'RAC1', 'FADD', 'NFKBIE', 'HRAS', 'SKP1', 'MAPK3']",0.9999897633382736,0,0,15
162,Vitamin A and carotenoid metabolism WP716,0.4067655081314321,1.217109663791586,1.094812545520455,"['CYP26B1', 'RBP4', 'RBP2', 'ALDH1A1', 'LPL', 'BCO1']",0.9999897633382736,0,0,6
163,BMP Signaling Pathway in Eyelid Development WP3927,0.40999438168225166,1.3995551961180752,1.2478599592285124,"['JUN', 'MAPK3', 'FGF10']",0.9999897633382736,0,0,3
164,miRNA targets in ECM and membrane receptors WP2911,0.40999438168225166,1.3995551961180752,1.2478599592285124,"['LAMA4', 'ITGA11', 'FN1']",0.9999897633382736,0,0,3
165,TP53 network WP1742,0.40999438168225166,1.3995551961180752,1.2478599592285124,"['CDKN1A', 'CDKN2A', 'BBC3']",0.9999897633382736,0,0,3
166,Tryptophan catabolism leading to NAD+ production WP4210,0.40999438168225166,1.3995551961180752,1.2478599592285124,"['TDO2', 'HAAO', 'KMO']",0.9999897633382736,0,0,3
167,B Cell Receptor Signaling Pathway WP23,0.41311590585978836,1.1072161257899737,0.9788090404555212,"['JUN', 'GSK3A', 'CD81', 'PDPK1', 'PRKCD', 'NFATC2', 'ELK1', 'ILF2', 'VAV2', 'NFKBIA', 'TEC', 'RAC1', 'HRAS', 'MEF2D']",0.9999897633382736,0,0,14
168,Pre-implantation embryo WP3527,0.4216112589232126,1.2277151803020299,1.060342705737998,"['EGR1', 'AQP9', 'HMGA1', 'FOSB', 'HNRNPAB']",0.9999897633382736,0,0,5
169,Fas ligand pathway and stress induction of heat shock proteins WP314,0.42500758088748525,1.1663628999594977,0.9979964008485668,"['DAXX', 'JUN', 'HSPB1', 'CYCS', 'FADD', 'ACTB', 'ACTG1']",0.9999897633382736,0,0,7
170,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.4260891602264219,1.5549717057396928,1.326556715644014,"['JAG1', 'WNT2']",0.9999897633382736,0,0,2
171,Canonical NF-KB pathway WP4562,0.4260891602264219,1.5549717057396928,1.326556715644014,"['NFKBIA', 'NFKBIE']",0.9999897633382736,0,0,2
172,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.4260891602264219,1.5549717057396928,1.326556715644014,"['CEBPB', 'ALDH1A1']",0.9999897633382736,0,0,2
173,IL1 and megakaryocytes in obesity WP2865,0.4260891602264219,1.5549717057396928,1.326556715644014,"['IL18', 'TIMP2']",0.9999897633382736,0,0,2
174,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.4385177935687362,1.110821457536786,0.915711100136609,"['FZD1', 'SFRP4', 'FRAT1', 'JUN', 'FRAT2', 'SFRP2', 'CSNK2B', 'WNT7A', 'WNT2', 'EZH2']",0.9999897633382736,0,0,10
175,Canonical and non-canonical Notch signaling WP3845,0.43907048443931995,1.2440129449838189,1.023941235505519,"['JAG1', 'HEY1', 'CNTN6', 'DLL3']",0.9999897633382736,0,0,4
176,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.43907048443931995,1.2440129449838189,1.023941235505519,"['LDHA', 'KEAP1', 'PDHB', 'ACACB']",0.9999897633382736,0,0,4
177,IL-7 signaling pathway WP205,0.43907048443931995,1.2440129449838189,1.023941235505519,"['CDKN1B', 'BAD', 'IL7', 'MAPK3']",0.9999897633382736,0,0,4
178,Striated Muscle Contraction Pathway WP383,0.43907048443931995,1.2440129449838189,1.023941235505519,"['MYOM1', 'MYBPC1', 'ACTC1', 'ACTG1']",0.9999897633382736,0,0,4
179,Ebola Virus Pathway on Host WP4217,0.44107706071059655,1.0718540826308212,0.8773508082007758,"['VPS18', 'VPS4A', 'CLTB', 'ACTB', 'ACTG1', 'RHOB', 'VAV2', 'RELB', 'IRF3', 'C1QBP', 'CLTCL1', 'TYRO3', 'RAC1', 'ITGA5', 'CTSB', 'HLA-DQB1', 'MAPK3']",0.9999897633382736,0,0,17
180,let-7 inhibition of ES cell reprogramming WP3299,0.44170318181118556,2.3323232323232324,1.9057813284475908,['EGR1'],0.9999897633382736,0,0,1
181,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.44170318181118556,2.3323232323232324,1.9057813284475908,['FURIN'],0.9999897633382736,0,0,1
182,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.44170318181118556,2.3323232323232324,1.9057813284475908,['MAS1'],0.9999897633382736,0,0,1
183,Wnt signaling pathway and pluripotency WP399,0.4559929841294165,1.0707275172790347,0.8408186083444713,"['PRKCG', 'FZD1', 'JUN', 'PRKCH', 'PRKCD', 'ESRRB', 'WNT7A', 'ZBTB33', 'PPP2CA', 'PTPA', 'FRAT1', 'PPP2R1A', 'PRKCQ', 'WNT2']",0.9999897633382736,0,0,14
184,T-cell receptor (TCR) signaling pathway WP69,0.4598445970306486,1.0765796703296704,0.8363588732963979,"['VAV3', 'NFKBIA', 'IL15RA', 'JUN', 'PDPK1', 'PRKCD', 'NFATC2', 'MAP3K8', 'PRKCQ', 'HRAS', 'SKAP1', 'MAPK3']",0.9999897633382736,0,0,12
185,Eicosanoid Synthesis WP167,0.4606884646355364,1.2722126236076903,0.9860070794428979,"['PTGES2', 'PNPLA3', 'PTGES']",0.9999897633382736,0,0,3
186,MAPK pathway in congenital thyroid cancer WP4928,0.4606884646355364,1.2722126236076903,0.9860070794428979,"['JUN', 'ELK1', 'MAPK3']",0.9999897633382736,0,0,3
187,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.4606884646355364,1.2722126236076903,0.9860070794428979,"['EGLN2', 'BCL2L2', 'RELB']",0.9999897633382736,0,0,3
188,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.4606884646355364,1.2722126236076903,0.9860070794428979,"['GSK3A', 'BCL2L14', 'BCL2L2']",0.9999897633382736,0,0,3
189,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.4606884646355364,1.2722126236076903,0.9860070794428979,"['NFKBIA', 'IRF3', 'NFKBIE']",0.9999897633382736,0,0,3
190,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.4640842954760452,1.084894094569871,0.8328613406477389,"['CACNB1', 'CACNB3', 'ITGA11', 'PKP2', 'ITGA8', 'CTNNA3', 'ITGA5', 'EMD', 'ACTB', 'ACTG1']",0.9999897633382736,0,0,10
191,ATM Signaling Network in Development and Disease  WP3878,0.4688518230301517,1.097626084469444,0.8314171868620764,"['PTPA', 'G6PD', 'TRIM28', 'ATMIN', 'CDK5', 'H2AFX', 'HSPB1', 'CDK5R1']",0.9999897633382736,0,0,8
192,Eukaryotic Transcription Initiation WP405,0.4688518230301517,1.097626084469444,0.8314171868620764,"['TAF13', 'TAF9', 'POLR2E', 'TAF6', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.9999897633382736,0,0,8
193,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.4740096411083809,1.0690415821501014,0.7980690654408585,"['FZD1', 'SFRP4', 'FRAT1', 'JUN', 'FRAT2', 'SFRP2', 'HNRNPK', 'CSNK2B', 'WNT7A', 'WNT2', 'EZH2']",0.9999897633382736,0,0,11
194,Urea cycle and associated pathways WP4595,0.48117536727536475,1.166161003236246,0.8530741627825846,"['LDHB', 'OAT', 'MDH2', 'GOT2']",0.9999897633382736,0,0,4
195,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.49012988957475984,1.3327174038572585,0.9503405796805181,"['TOB1', 'RUNX2']",0.9999897633382736,0,0,2
196,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.49012988957475984,1.3327174038572585,0.9503405796805181,"['PRKCQ', 'MAFK']",0.9999897633382736,0,0,2
197,miR-509-3p alteration of YAP1/ECM axis WP3967,0.49012988957475984,1.3327174038572585,0.9503405796805181,"['SPARC', 'FN1']",0.9999897633382736,0,0,2
198,Purine metabolism WP4792,0.49012988957475984,1.3327174038572585,0.9503405796805181,"['PRPS1', 'APRT']",0.9999897633382736,0,0,2
199,Trans-sulfuration pathway WP2333,0.49012988957475984,1.3327174038572585,0.9503405796805181,"['AHCY', 'MAT2B']",0.9999897633382736,0,0,2
200,Endothelin Pathways WP2197,0.49584655645996906,1.1105972133896052,0.7790714644072371,"['ADCY10', 'GNAS', 'CALM1', 'CALM2', 'GNG13']",0.9999897633382736,0,0,5
201,Ciliary landscape WP4352,0.5001387533916887,1.0140177760361933,0.7025822047233782,"['DOCK5', 'GDI1', 'ZMYND19', 'SSNA1', 'VPS4A', 'COPS7A', 'PSMD8', 'EXOSC4', 'ARHGDIA', 'NEFL', 'NEFM', 'TMED1', 'RAC1', 'DCAF11', 'NINL', 'NUDC', 'EXOC8', 'RHBDD2', 'DYNLT3', 'H3F3A', 'DYNLL1', 'WDR34', 'DYNLL2', 'LSM4', 'EHD3', 'ERF', 'MCM3', 'CD2BP2', 'ANKS6', 'MCM4', 'DYNLRB1', 'CALM1', 'YPEL5', 'COPS8', 'CALM2']",0.9999897633382736,0,0,35
202,Osteoblast differentiation WP4787,0.5054599987995944,1.028903841097593,0.7020070725855322,"['PRKCG', 'FZD1', 'PRKCH', 'JAG1', 'PRKCD', 'WNT7A', 'FGF1', 'RUNX2', 'DLL3', 'HEY1', 'PRKCQ', 'PPARG', 'WNT2', 'FGF10', 'MAPK3']",0.9999897633382736,0,0,15
203,Folate Metabolism WP176,0.5073903729699606,1.076393646838991,0.7303057546357511,"['AHCY', 'GPX4', 'GPX3', 'SHMT2', 'RFK', 'SOD1']",0.9999897633382736,0,0,6
204,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.5093910655640923,1.1660938131823695,0.7865760528514872,"['JUN', 'PRKCQ', 'MAPK3']",0.9999897633382736,0,0,3
205,Aryl Hydrocarbon Receptor Netpath WP2586,0.5169909017563844,1.0532147010021036,0.6948373376186687,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'AIP', 'LPL', 'AHRR', 'HRAS']",0.9999897633382736,0,0,7
206,Interleukin-11 Signaling Pathway WP2332,0.5169909017563844,1.0532147010021036,0.6948373376186687,"['PTPA', 'BGLAP', 'PDPK1', 'IL6ST', 'HRAS', 'RUNX2', 'MAPK3']",0.9999897633382736,0,0,7
207,TGF-beta Receptor Signaling WP560,0.5169909017563844,1.0532147010021036,0.6948373376186687,"['FKBP1A', 'JUN', 'ZNF423', 'HRAS', 'LTBP1', 'RUNX2', 'MAPK3']",0.9999897633382736,0,0,7
208,Apoptosis WP254,0.5217995747254833,1.026101419878296,0.6674499568107054,"['NFKBIA', 'JUN', 'IRF3', 'CRADD', 'CDKN2A', 'BAD', 'CYCS', 'FADD', 'NFKBIE', 'BCL2L2', 'BBC3']",0.9999897633382736,0,0,11
209,Cardiac Progenitor Differentiation WP2406,0.5219659023986635,1.0974681134589759,0.7135222020726734,"['MESP1', 'ACTC1', 'NRG1', 'THY1']",0.9999897633382736,0,0,4
210,Differentiation Pathway WP2848,0.5219659023986635,1.0974681134589759,0.7135222020726734,"['TPO', 'FGF1', 'WNT2', 'FGF10']",0.9999897633382736,0,0,4
211,Glycerolipids and Glycerophospholipids WP4722,0.5219659023986635,1.0974681134589759,0.7135222020726734,"['PCYT2', 'PNPLA3', 'PLD1', 'CDIPT']",0.9999897633382736,0,0,4
212,Type II interferon signaling (IFNG) WP619,0.5219659023986635,1.0974681134589759,0.7135222020726734,"['SPI1', 'PRKCD', 'TAP1', 'ISG15']",0.9999897633382736,0,0,4
213,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.5252684112686978,1.0364667747163696,0.6673248704105134,"['PPP1R15A', 'PPP1CC', 'XBP1', 'PPP1R11', 'HSPA5', 'PPP1R1A', 'PPP1R1B', 'PPP1R9B']",0.9999897633382736,0,0,8
214,Phosphodiesterases in neuronal function WP4222,0.5252684112686978,1.0364667747163696,0.6673248704105134,"['ADCY10', 'PDE10A', 'ADORA2A', 'PPP1R1B', 'PDE3A', 'PDE6B', 'DRD1', 'GRIN2D']",0.9999897633382736,0,0,8
215,Alpha 6 Beta 4 signaling pathway WP244,0.5316099591900443,1.06002354585924,0.6697708083660973,"['LAMA3', 'PRKCD', 'RAC1', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,5
216,GABA receptor Signaling WP4159,0.5316099591900443,1.06002354585924,0.6697708083660973,"['GABBR1', 'AP2S1', 'GABRD', 'GABRG3', 'AP2M1']",0.9999897633382736,0,0,5
217,Intraflagellar transport proteins binding to dynein WP4532,0.5316099591900443,1.06002354585924,0.6697708083660973,"['DYNLT3', 'DYNLRB1', 'WDR34', 'DYNLL1', 'DYNLL2']",0.9999897633382736,0,0,5
218,p38 MAPK Signaling Pathway WP400,0.5395971847110822,1.0364372469635628,0.6394116892241419,"['DAXX', 'HSPB1', 'RAC1', 'ELK1', 'HRAS', 'MEF2D']",0.9999897633382736,0,0,6
219,Parkinson's disease pathway WP2371,0.5395971847110822,1.0364372469635628,0.6394116892241419,"['PINK1', 'UBB', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7']",0.9999897633382736,0,0,6
220,Cells and molecules involved in local acute inflammatory response  WP4493,0.5403009308740265,1.5547474747474748,0.9571476568411637,['SELP'],0.9999897633382736,0,0,1
221,Codeine and Morphine Metabolism WP1604,0.5403009308740265,1.5547474747474748,0.9571476568411637,['ABCB1'],0.9999897633382736,0,0,1
222,Composition of Lipid Particles WP3601,0.5403009308740265,1.5547474747474748,0.9571476568411637,['LPL'],0.9999897633382736,0,0,1
223,Fatty Acid Omega Oxidation WP206,0.5403009308740265,1.5547474747474748,0.9571476568411637,['ALDH1A1'],0.9999897633382736,0,0,1
224,FOXP3 in COVID-19 WP5063,0.5403009308740265,1.5547474747474748,0.9571476568411637,['IL6ST'],0.9999897633382736,0,0,1
225,Platelet-mediated interactions with vascular and circulating cells WP4462,0.5403009308740265,1.5547474747474748,0.9571476568411637,['SELP'],0.9999897633382736,0,0,1
226,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.5403009308740265,1.5547474747474748,0.9571476568411637,['RAC1'],0.9999897633382736,0,0,1
227,Role of Osx and miRNAs in tooth development WP3971,0.5403009308740265,1.5547474747474748,0.9571476568411637,['RUNX2'],0.9999897633382736,0,0,1
228,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5403009308740265,1.5547474747474748,0.9571476568411637,['DLL3'],0.9999897633382736,0,0,1
229,Breast cancer pathway WP4262,0.5467508337218995,0.9955595798292427,0.6010811371748229,"['SHC4', 'FZD1', 'JUN', 'CDKN1A', 'GADD45B', 'WNT7A', 'FGF1', 'DLL3', 'FGF17', 'SFRP4', 'FRAT1', 'FRAT2', 'HEY1', 'CSNK2B', 'WNT2', 'HRAS', 'SKP1', 'FGF10', 'MAPK3']",0.9999897633382736,0,0,19
230,Hedgehog Signaling Pathway Netpath WP47,0.5494568986081867,1.1660266774454324,0.6982458617926827,"['GRK2', 'SAP18']",0.9999897633382736,0,0,2
231,ID signaling pathway WP53,0.5494568986081867,1.1660266774454324,0.6982458617926827,"['ID2', 'ELK1']",0.9999897633382736,0,0,2
232,Neuroinflammation WP4919,0.5494568986081867,1.1660266774454324,0.6982458617926827,"['NFKBIA', 'JUN']",0.9999897633382736,0,0,2
233,RANKL/RANK signaling pathway WP2018,0.5526623577316575,1.0083665513163083,0.5979694607132249,"['NFKBIA', 'JUN', 'SPI1', 'MITF', 'RAC1', 'PAPSS2', 'RELB', 'MAPK3']",0.9999897633382736,0,0,8
234,Microglia Pathogen Phagocytosis Pathway WP3937,0.5556655404603547,1.0763009735917135,0.632422302439247,"['VAV3', 'RAC1', 'VAV2']",0.9999897633382736,0,0,3
235,Transcription factor regulation in adipogenesis WP3599,0.5556655404603547,1.0763009735917135,0.632422302439247,"['CEBPA', 'CEBPB', 'PPARG']",0.9999897633382736,0,0,3
236,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.5563411643851726,0.9873963355834137,0.5789831122282525,"['CDKN1A', 'CDKN1B', 'CHRM1', 'HSP90AB1', 'LAMA4', 'LAMA3', 'SLC2A3', 'FGF1', 'HSP90B1', 'PPP2CA', 'GNG10', 'GNG3', 'PPP2R1A', 'PDGFD', 'PELO', 'HRAS', 'EIF4B', 'MAPK3', 'HSP90AA1', 'ANGPT2', 'PDPK1', 'BAD', 'FN1', 'GNG13', 'RAB11B', 'EFNA1', 'FGF17', 'CREB3', 'EFNA3', 'LPAR6', 'GNB2', 'DDIT4', 'ITGA11', 'ITGA8', 'ITGA5', 'FGF10']",0.9999897633382736,0,0,36
237,7-oxo-C and 7beta-HC pathways WP5064,0.5611532077337194,1.0364077669902914,0.5987963124454647,"['HSD11B1', 'HSD11B2', 'DBP', 'ACOT6']",0.9999897633382736,0,0,4
238,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.5611532077337194,1.0364077669902914,0.5987963124454647,"['PPP2CA', 'CDKN1A', 'THRA', 'MAPK3']",0.9999897633382736,0,0,4
239,Unfolded protein response WP4925,0.5611532077337194,1.0364077669902914,0.5987963124454647,"['PPP1R15A', 'XBP1', 'HSPA5', 'BBC3']",0.9999897633382736,0,0,4
240,Prolactin Signaling Pathway WP2037,0.5681619072389228,0.9864643470120144,0.5576964870332562,"['NFKBIA', 'JUN', 'TEC', 'RAC1', 'ELK1', 'CTSD', 'HRAS', 'PPIA', 'YWHAG', 'VAV2', 'MAPK3']",0.9999897633382736,0,0,11
241,Ferroptosis WP4313,0.5708535436226172,0.9993348756506651,0.5602497095167073,"['PRNP', 'MAP1LC3B', 'GPX4', 'FTH1', 'PCBP1', 'CP']",0.9999897633382736,0,0,6
242,Prader-Willi and Angelman Syndrome WP3998,0.575236042375732,0.989211679369638,0.5470091443474983,"['CDKN2C', 'CDKN2A', 'NDN', 'GHRL', 'TYR', 'GABRG3', 'GABRD']",0.9999897633382736,0,0,7
243,3q29 copy number variation syndrome WP4906,0.5833048813998382,0.9760088988603048,0.5261129869139948,"['JUN', 'DYNLT3', 'MAD2L1BP', 'FBXO45', 'SLC51A', 'DYNLRB1', 'WDR34', 'DYNLL1', 'DYNLL2']",0.9999897633382736,0,0,9
244,PI3K-Akt signaling pathway WP4172,0.5941458896507779,0.97001800435895,0.5050208463901212,"['CDKN1A', 'CDKN1B', 'CHRM1', 'HSP90AB1', 'FLT3', 'LAMA4', 'LAMA3', 'FGF1', 'HSP90B1', 'PPP2CA', 'GNG10', 'GNG3', 'PPP2R1A', 'PDGFD', 'RAC1', 'HRAS', 'EIF4B', 'MAPK3', 'HSP90AA1', 'ANGPT2', 'PDPK1', 'BAD', 'FN1', 'GNG13', 'EFNA1', 'FGF17', 'CREB3', 'EFNA3', 'LPAR6', 'IL7', 'GNB2', 'DDIT4', 'ITGA11', 'ITGA8', 'ITGA5', 'FGF10']",0.9999897633382736,0,0,36
245,Wnt signaling WP428,0.5974110298556244,0.9621251667536685,0.4956386933227164,"['PRKCG', 'FZD1', 'JUN', 'NFATC2', 'WNT7A', 'SFRP4', 'FRAT1', 'FRAT2', 'SFRP2', 'CSNK2B', 'RAC1', 'WNT2', 'PLCB2']",0.9999897633382736,0,0,13
246,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5985166628835143,0.9817748254130472,0.5039459145359826,"['LPL', 'FOXO4', 'PRDM1', 'RAC1']",0.9999897633382736,0,0,4
247,Constitutive Androstane Receptor Pathway WP2875,0.5992135415574709,0.9993356825140084,0.5117970259106772,"['PTPA', 'HSP90AA1', 'ABCB1']",0.9999897633382736,0,0,3
248,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.5992135415574709,0.9993356825140084,0.5117970259106772,"['RAB5C', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,3
249,Nanomaterial induced apoptosis WP2507,0.5992135415574709,0.9993356825140084,0.5117970259106772,"['ENDOG', 'CYCS', 'FADD']",0.9999897633382736,0,0,3
250,Triacylglyceride synthesis WP325,0.5992135415574709,0.9993356825140084,0.5117970259106772,"['MOGAT1', 'LPL', 'AGPAT1']",0.9999897633382736,0,0,3
251,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6037377872298677,1.036378334680679,0.522972366766729,"['CDKN1A', 'PHEX']",0.9999897633382736,0,0,2
252,GDNF/RET signaling axis WP4830,0.6037377872298677,1.036378334680679,0.522972366766729,"['GFRA1', 'FAT4']",0.9999897633382736,0,0,2
253,Leptin Insulin Overlap WP3935,0.6037377872298677,1.036378334680679,0.522972366766729,"['PDPK1', 'LEPR']",0.9999897633382736,0,0,2
254,RAS and bradykinin pathways in COVID-19 WP4969,0.6037377872298677,1.036378334680679,0.522972366766729,"['F12', 'SERPING1']",0.9999897633382736,0,0,2
255,Pyrimidine metabolism WP4022,0.6174936153237313,0.9470094904587901,0.45654053815792683,"['NME2', 'DCK', 'NME1', 'TYMP', 'UCK1', 'POLE3', 'POLR2E', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999897633382736,0,0,13
256,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.6214916187139478,1.1659595959595959,0.5545686899242483,['SPI1'],0.9999897633382736,0,0,1
257,Complement Activation WP545,0.6214916187139478,1.1659595959595959,0.5545686899242483,['C2'],0.9999897633382736,0,0,1
258,Cytokines and Inflammatory Response WP530,0.6214916187139478,1.1659595959595959,0.5545686899242483,['IL7'],0.9999897633382736,0,0,1
259,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.6214916187139478,1.1659595959595959,0.5545686899242483,['FN1'],0.9999897633382736,0,0,1
260,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6214916187139478,1.1659595959595959,0.5545686899242483,['HEY1'],0.9999897633382736,0,0,1
261,Mitochondrial fatty acid synthesis pathway WP4317,0.6214916187139478,1.1659595959595959,0.5545686899242483,['MCAT'],0.9999897633382736,0,0,1
262,PTF1A related regulatory pathway WP4147,0.6214916187139478,1.1659595959595959,0.5545686899242483,['FGF10'],0.9999897633382736,0,0,1
263,SARS-CoV-2 and COVID-19 Pathway WP4846,0.6214916187139478,1.1659595959595959,0.5545686899242483,['FURIN'],0.9999897633382736,0,0,1
264,Somatic sex determination WP4814,0.6214916187139478,1.1659595959595959,0.5545686899242483,['AMH'],0.9999897633382736,0,0,1
265,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.6214916187139478,1.1659595959595959,0.5545686899242483,['MAPK3'],0.9999897633382736,0,0,1
266,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6299069304719829,0.932523288780883,0.43099659760790016,"['FKBP1A', 'JUN', 'ZNF423', 'HRAS', 'LTBP1', 'RUNX2', 'MAPK3']",0.9999897633382736,0,0,7
267,Base Excision Repair WP4752,0.6311151949954276,0.9325779036827195,0.42923471619168724,"['FEN1', 'PCNA', 'NEIL2', 'POLE3', 'APEX2']",0.9999897633382736,0,0,5
268,Bladder cancer WP2828,0.6311151949954276,0.9325779036827195,0.42923471619168724,"['CDKN1A', 'CDKN2A', 'DAPK2', 'HRAS', 'TYMP']",0.9999897633382736,0,0,5
269,miRNA regulation of prostate cancer signaling pathways WP3981,0.6311151949954276,0.9325779036827195,0.42923471619168724,"['NFKBIA', 'AR', 'CDKN1A', 'CDKN1B', 'BAD']",0.9999897633382736,0,0,5
270,Neural Crest Cell Migration during Development WP4564,0.6311151949954276,0.9325779036827195,0.42923471619168724,"['ARF1', 'JUN', 'PAK6', 'RAC1', 'EPHB3']",0.9999897633382736,0,0,5
271,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6311151949954276,0.9325779036827195,0.42923471619168724,"['NFKBIA', 'TEC', 'TNFSF4', 'RELB', 'MAPK3']",0.9999897633382736,0,0,5
272,Oxidative Stress WP408,0.6338977165281188,0.9326051779935275,0.42514454761685727,"['GPX3', 'NOX4', 'JUNB', 'SOD1']",0.9999897633382736,0,0,4
273,Apoptosis Modulation by HSP70 WP384,0.6398535706082955,0.932632430246664,0.41643523202546495,"['CYCS', 'FADD', 'HSPA1A']",0.9999897633382736,0,0,3
274,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6398535706082955,0.932632430246664,0.41643523202546495,"['B3GALT1', 'B4GALNT1', 'ST6GALNAC3']",0.9999897633382736,0,0,3
275,Methionine De Novo and Salvage Pathway WP3580,0.6398535706082955,0.932632430246664,0.41643523202546495,"['AHCY', 'AMD1', 'MAT2B']",0.9999897633382736,0,0,3
276,Monoamine Transport WP727,0.6398535706082955,0.932632430246664,0.41643523202546495,"['TDO2', 'ADORA2A', 'SYN1']",0.9999897633382736,0,0,3
277,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6398535706082955,0.932632430246664,0.41643523202546495,"['PTGES2', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,3
278,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6398535706082955,0.932632430246664,0.41643523202546495,"['MDH2', 'IDH3G', 'IDH3B']",0.9999897633382736,0,0,3
279,Toll-like Receptor Signaling related to MyD88 WP3858,0.6398535706082955,0.932632430246664,0.41643523202546495,"['IRF3', 'TOLLIP', 'RELB']",0.9999897633382736,0,0,3
280,TYROBP causal network in microglia WP3945,0.6398535706082955,0.932632430246664,0.41643523202546495,"['RBM47', 'IGSF6', 'IL18']",0.9999897633382736,0,0,3
281,NOTCH1 regulation of endothelial cell calcification WP3413,0.6529043648693504,0.9326596604688763,0.39761577110002316,"['JAG1', 'DLL3']",0.9999897633382736,0,0,2
282,Overview of nanoparticle effects WP3287,0.6529043648693504,0.9326596604688763,0.39761577110002316,"['LAMA3', 'FN1']",0.9999897633382736,0,0,2
283,Copper homeostasis WP3286,0.6556928307806604,0.9065411097610369,0.38261732031267753,"['PRNP', 'MT2A', 'JUN', 'SCO2', 'MT3', 'ATOX1', 'SOD1']",0.9999897633382736,0,0,7
284,Glycosylation and related congenital defects WP4521,0.6671929403339147,0.8881183541377716,0.3594001910968828,"['MPI', 'PMM2', 'DOLK', 'MGAT2']",0.9999897633382736,0,0,4
285,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6775003643200663,0.8742670845127376,0.3403916828072686,"['FZD1', 'FGF1', 'RUNX2']",0.9999897633382736,0,0,3
286,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6775003643200663,0.8742670845127376,0.3403916828072686,"['BAD', 'FADD', 'BBC3']",0.9999897633382736,0,0,3
287,Nucleotide metabolism WP404,0.6775003643200663,0.8742670845127376,0.3403916828072686,"['PRPS1', 'NME2', 'OAZ1']",0.9999897633382736,0,0,3
288,IL-4 signaling pathway WP395,0.6803677006765809,0.8819633728503716,0.33966340165213244,"['NFKBIA', 'CEBPA', 'CEBPB', 'BAD', 'ELK1', 'MAPK3', 'SOCS5']",0.9999897633382736,0,0,7
289,Cellular Proteostasis WP4918,0.6883473696686108,0.9326868686868687,0.3483227962128887,['PFDN6'],0.9999897633382736,0,0,1
290,LDLRAD4 and what we know about it WP4904,0.6883473696686108,0.9326868686868687,0.3483227962128887,['PMEPA1'],0.9999897633382736,0,0,1
291,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.6883473696686108,0.9326868686868687,0.3483227962128887,['IL6ST'],0.9999897633382736,0,0,1
292,miRNA Biogenesis WP2338,0.6883473696686108,0.9326868686868687,0.3483227962128887,['RAN'],0.9999897633382736,0,0,1
293,Nephrogenesis WP5052,0.6883473696686108,0.9326868686868687,0.3483227962128887,['JAG1'],0.9999897633382736,0,0,1
294,Peroxiredoxin 2 induced ovarian failure WP4873,0.6883473696686108,0.9326868686868687,0.3483227962128887,['PRDX2'],0.9999897633382736,0,0,1
295,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.6883473696686108,0.9326868686868687,0.3483227962128887,['NFKBIA'],0.9999897633382736,0,0,1
296,Serine Metabolism WP4688,0.6883473696686108,0.9326868686868687,0.3483227962128887,['SHMT2'],0.9999897633382736,0,0,1
297,Target Of Rapamycin (TOR) Signaling WP1471,0.6897480083238918,0.8633481721300418,0.32067250801325803,"['FKBP1A', 'RRAGA', 'RRAGC', 'DDIT4', 'RAC1']",0.9999897633382736,0,0,5
298,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6926883930190066,0.9002319863950609,0.3305427068258463,"['FZD1', 'SPARC', 'JAG1', 'EIF5A2', 'FN1', 'WNT7A', 'DLL3', 'CLDN20', 'MMP15', 'ID2', 'PKP2', 'ITGA5', 'WNT2', 'HRAS', 'MEF2D', 'EZH2', 'MAPK3']",0.9999897633382736,0,0,17
299,Biomarkers for pyrimidine metabolism disorders WP4584,0.6970697706291575,0.8477989270228559,0.30594500541039216,"['CKB', 'TYMP']",0.9999897633382736,0,0,2
300,Phytochemical activity on NRF2 transcriptional activation WP3,0.6970697706291575,0.8477989270228559,0.30594500541039216,"['CEBPB', 'KEAP1']",0.9999897633382736,0,0,2
301,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6970697706291575,0.8477989270228559,0.30594500541039216,"['LDHA', 'SLC2A3']",0.9999897633382736,0,0,2
302,Endometrial cancer WP4155,0.6973829781672252,0.8739612890149979,0.31499361073698406,"['CDKN1A', 'GADD45B', 'PDPK1', 'BAD', 'CTNNA3', 'FGF1', 'ELK1', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,9
303,Glycerophospholipid Biosynthetic Pathway WP2533,0.6983467982265105,0.8476757869961753,0.3043490517405618,"['PCYT2', 'PTPMT1', 'GPAT3', 'CDIPT']",0.9999897633382736,0,0,4
304,Oxidation by Cytochrome P450 WP43,0.6983467982265105,0.8476757869961753,0.3043490517405618,"['CYP39A1', 'CYP26B1', 'CYP2C18', 'CYP3A7']",0.9999897633382736,0,0,4
305,AGE/RAGE pathway WP2324,0.7001129223095083,0.8672119407485583,0.3091728850961887,"['NFKBIA', 'JUN', 'PRKCD', 'CYCS', 'RAC1', 'FOXO4', 'MAPK3', 'SOD1']",0.9999897633382736,0,0,8
306,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7091453030893508,0.8475524475524475,0.291299396547242,"['ACAN', 'THRA', 'CALM1', 'SLC38A2', 'CALM2', 'RUNX2']",0.9999897633382736,0,0,6
307,Endochondral Ossification WP474,0.7091453030893508,0.8475524475524475,0.291299396547242,"['ACAN', 'THRA', 'CALM1', 'SLC38A2', 'CALM2', 'RUNX2']",0.9999897633382736,0,0,6
308,One-carbon metabolism and related pathways WP3940,0.7091453030893508,0.8475524475524475,0.291299396547242,"['PCYT2', 'GPX4', 'GPX3', 'SHMT2', 'PLD1', 'SOD1']",0.9999897633382736,0,0,6
309,Focal Adhesion WP306,0.71039435771652,0.901673419986318,0.3083137276781265,"['PRKCG', 'VAV3', 'SHC4', 'JUN', 'PDPK1', 'BAD', 'TXK', 'LAMA4', 'LAMA3', 'FN1', 'ELK1', 'ACTB', 'MYL12B', 'VAV2', 'ACTG1', 'PPP1CC', 'PDGFD', 'ITGA11', 'ITGA8', 'PAK6', 'RAC1', 'ITGA5', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,24
310,Glioblastoma signaling pathways WP2261,0.7110847022084502,0.8738078327922078,0.2979367737599222,"['PRKCG', 'CDKN1A', 'CDKN1B', 'PRKCH', 'CDKN2C', 'PDPK1', 'CDKN2A', 'PRKCD', 'PRKCQ', 'FOXO4', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,12
311,NRF2-ARE regulation WP4357,0.7121459155349334,0.822768250041626,0.2793071544613625,"['CEBPB', 'KEAP1', 'PGAM5']",0.9999897633382736,0,0,3
312,SARS-CoV-2 mitochondrial interactions WP5038,0.7121459155349334,0.822768250041626,0.2793071544613625,"['IRF3', 'PHB', 'PHB2']",0.9999897633382736,0,0,3
313,Signal Transduction of S1P Receptor WP26,0.7121459155349334,0.822768250041626,0.2793071544613625,"['SMPD2', 'PLCB2', 'MAPK3']",0.9999897633382736,0,0,3
314,Vitamin B12 metabolism WP1533,0.7121459155349334,0.822768250041626,0.2793071544613625,"['CUBN', 'SHMT2', 'SOD1']",0.9999897633382736,0,0,3
315,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.714830645485734,0.8630711002973777,0.28974127439717307,"['CDKN1A', 'JUN', 'GADD45B', 'DCC', 'BAD', 'CYCS', 'RAC1', 'NTN1', 'BBC3', 'MAPK3']",0.9999897633382736,0,0,10
316,Neural Crest Cell Migration in Cancer WP4565,0.7165606286669965,0.8324420419725964,0.27744662057707065,"['ARF1', 'JUN', 'PAK6', 'RAC1', 'EPHB3']",0.9999897633382736,0,0,5
317,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.7273444782040445,0.8107499648234135,0.2581063686581849,"['CDKN1B', 'BAD', 'FOXO4', 'HRAS']",0.9999897633382736,0,0,4
318,Type II diabetes mellitus WP1584,0.7364666074173892,0.7770816491511722,0.2377025808778229,"['KCNJ11', 'PRKCD']",0.9999897633382736,0,0,2
319,ATM Signaling Pathway WP2516,0.7416825123347379,0.8036673690673886,0.2401631412643775,"['NFKBIA', 'CDKN1A', 'JUN', 'CRADD', 'H2AFX']",0.9999897633382736,0,0,5
320,DNA Replication WP466,0.7416825123347379,0.8036673690673886,0.2401631412643775,"['PCNA', 'UBC', 'MCM3', 'MCM4', 'UBA52']",0.9999897633382736,0,0,5
321,Nephrotic syndrome WP4758,0.7416825123347379,0.8036673690673886,0.2401631412643775,"['CUBN', 'MYO1E', 'ARHGDIA', 'PMM2', 'SYNPO']",0.9999897633382736,0,0,5
322,Bile acids synthesis and enterohepatic circulation  WP4389,0.7433982987057578,0.7771717171717172,0.23044952974446534,['MAPK3'],0.9999897633382736,0,0,1
323,Cell Differentiation - Index WP2029,0.7433982987057578,0.7771717171717172,0.23044952974446534,['MEF2D'],0.9999897633382736,0,0,1
324,"Cerebral organic acidurias, including diseases WP4519",0.7433982987057578,0.7771717171717172,0.23044952974446534,['MDH2'],0.9999897633382736,0,0,1
325,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.7433982987057578,0.7771717171717172,0.23044952974446534,['DHCR24'],0.9999897633382736,0,0,1
326,Estrogen metabolism WP697,0.7433982987057578,0.7771717171717172,0.23044952974446534,['ARSE'],0.9999897633382736,0,0,1
327,Glial Cell Differentiation WP2276,0.7433982987057578,0.7771717171717172,0.23044952974446534,['TPPP'],0.9999897633382736,0,0,1
328,Inflammatory Response Pathway WP453,0.7433982987057578,0.7771717171717172,0.23044952974446534,['FN1'],0.9999897633382736,0,0,1
329,Liver X receptor pathway WP2874,0.7433982987057578,0.7771717171717172,0.23044952974446534,['FASN'],0.9999897633382736,0,0,1
330,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.7433982987057578,0.7771717171717172,0.23044952974446534,['LPL'],0.9999897633382736,0,0,1
331,Methylation Pathways WP704,0.7433982987057578,0.7771717171717172,0.23044952974446534,['MAT2B'],0.9999897633382736,0,0,1
332,Osteoblast Signaling WP322,0.7433982987057578,0.7771717171717172,0.23044952974446534,['BGLAP'],0.9999897633382736,0,0,1
333,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.7433982987057578,0.7771717171717172,0.23044952974446534,['JUN'],0.9999897633382736,0,0,1
334,Supression of HMGB1 mediated inflammation by THBD WP4479,0.7433982987057578,0.7771717171717172,0.23044952974446534,['NFKBIA'],0.9999897633382736,0,0,1
335,Fatty Acid Biosynthesis WP357,0.7438425465663648,0.7769915082895269,0.2299319094445157,"['ACLY', 'FASN', 'ACACB']",0.9999897633382736,0,0,3
336,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7438425465663648,0.7769915082895269,0.2299319094445157,"['EI24', 'SHISA5', 'BBC3']",0.9999897633382736,0,0,3
337,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7438425465663648,0.7769915082895269,0.2299319094445157,"['FZD1', 'PLOD2', 'P4HB']",0.9999897633382736,0,0,3
338,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7542050352766617,0.7769012944983819,0.2191568769459289,"['HEXIM1', 'NFKBIA', 'SUPT4H1', 'NFATC2']",0.9999897633382736,0,0,4
339,PDGFR-beta pathway WP3972,0.7542050352766617,0.7769012944983819,0.2191568769459289,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,4
340,Tumor suppressor activity of SMARCB1 WP4204,0.7542050352766617,0.7769012944983819,0.2191568769459289,"['H3F3B', 'CDKN2A', 'H3F3A', 'EZH2']",0.9999897633382736,0,0,4
341,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7550126251105985,0.7989820705610179,0.22453058694440498,"['CDKN1A', 'HSP90AA1', 'JUN', 'CDKN2A', 'ELK1', 'JUNB']",0.9999897633382736,0,0,6
342,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7607249968241782,0.810443238672398,0.22164273775380586,"['NFKBIA', 'ANGPT2', 'BAD', 'STMN1', 'FN1', 'RAC1', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,8
343,Pathways Regulating Hippo Signaling WP4540,0.7641529997940801,0.8266374402931361,0.22235493045142335,"['PRKCG', 'PRKCH', 'PRKD3', 'PRKAR1A', 'FLT3', 'PRKCD', 'GNAS', 'PRKCQ', 'RAC1', 'PLCB2', 'CDH7']",0.9999897633382736,0,0,11
344,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7651248109048997,0.7768110076891946,0.20796497417952453,"['CDKN1A', 'JUN', 'RAC1', 'VAV2', 'MAPK3']",0.9999897633382736,0,0,5
345,IL-3 signaling pathway WP286,0.7651248109048997,0.7768110076891946,0.20796497417952453,"['JUN', 'YWHAB', 'BAD', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,5
346,Netrin-UNC5B signaling pathway WP4747,0.7651248109048997,0.7768110076891946,0.20796497417952453,"['PTPA', 'JUN', 'RAC1', 'NTN1', 'MAPK3']",0.9999897633382736,0,0,5
347,Cardiac Hypertrophic Response WP2795,0.7673760289525925,0.7956415651641328,0.21066865155601833,"['PDPK1', 'NFATC2', 'NRG1', 'RAC1', 'CALM1', 'CALM2', 'MAPK3']",0.9999897633382736,0,0,7
348,ERK Pathway in Huntington's Disease WP3853,0.7714012573124057,0.7172439524905168,0.18615823160606182,"['ELK1', 'HRAS']",0.9999897633382736,0,0,2
349,Glycosaminoglycan degradation WP4815,0.7714012573124057,0.7172439524905168,0.18615823160606182,"['HYAL1', 'IDS']",0.9999897633382736,0,0,2
350,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.7714012573124057,0.7172439524905168,0.18615823160606182,"['ABCB1', 'PPARG']",0.9999897633382736,0,0,2
351,Estrogen signaling pathway WP712,0.7726881927914604,0.7360333709323855,0.18980805356259317,"['JUN', 'GNAS', 'ELK1']",0.9999897633382736,0,0,3
352,MET in type 1 papillary renal cell carcinoma WP4205,0.7788569717547207,0.7931307976137109,0.19822547890669615,"['CDKN1A', 'JUN', 'BAD', 'RPL11', 'PAK6', 'RAC1', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,8
353,"Degradation pathway of sphingolipids, including diseases WP4153",0.7887281046800215,0.6660894660894661,0.15808542758145308,['NEU1'],0.9999897633382736,0,0,1
354,Farnesoid X receptor pathway WP2879,0.7887281046800215,0.6660894660894661,0.15808542758145308,['FKBP5'],0.9999897633382736,0,0,1
355,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.7887281046800215,0.6660894660894661,0.15808542758145308,['ELOB'],0.9999897633382736,0,0,1
356,Iron metabolism in placenta WP2007,0.7887281046800215,0.6660894660894661,0.15808542758145308,['FTH1'],0.9999897633382736,0,0,1
357,Leptin and adiponectin WP3934,0.7887281046800215,0.6660894660894661,0.15808542758145308,['LEPR'],0.9999897633382736,0,0,1
358,Mitochondrial CII Assembly WP4920,0.7887281046800215,0.6660894660894661,0.15808542758145308,['SDHAF1'],0.9999897633382736,0,0,1
359,Vitamin B12 Disorders WP4271,0.7887281046800215,0.6660894660894661,0.15808542758145308,['CUBN'],0.9999897633382736,0,0,1
360,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7895433877663902,0.7911679451782395,0.1869533737436502,"['EGR1', 'JUN', 'CDKN1B', 'PDPK1', 'GNAS', 'PLD1', 'HRAS', 'MYL12B', 'MAPK3']",0.9999897633382736,0,0,9
361,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7953506661850478,0.7556625451362293,0.17302569428780168,"['ADCY10', 'CFL1', 'BANF1', 'HRAS', 'EMD', 'MAPK3']",0.9999897633382736,0,0,6
362,Toll-like Receptor Signaling Pathway WP75,0.795962248446698,0.7765397082658023,0.1772090954959382,"['NFKBIA', 'JUN', 'IRF3', 'TOLLIP', 'MAP3K8', 'FADD', 'RAC1', 'MAPK3']",0.9999897633382736,0,0,8
363,Cannabinoid receptor signaling WP3869,0.798813882591103,0.6991710473109584,0.157052903395614,"['ADORA2A', 'PRKAR1A', 'MAPK3']",0.9999897633382736,0,0,3
364,Signal transduction through IL1R WP4496,0.798813882591103,0.6991710473109584,0.157052903395614,"['NFKBIA', 'JUN', 'TOLLIP']",0.9999897633382736,0,0,3
365,Wnt signaling in kidney disease WP4150,0.798813882591103,0.6991710473109584,0.157052903395614,"['FZD1', 'WNT7A', 'WNT2']",0.9999897633382736,0,0,3
366,MAPK Cascade WP422,0.801722643515839,0.7170151854617874,0.15845502279698365,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,4
367,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8022205956812397,0.665954498209955,0.14675749291250872,"['PRXL2B', 'PTGES']",0.9999897633382736,0,0,2
368,Urea cycle and metabolism of amino groups WP497,0.8022205956812397,0.665954498209955,0.14675749291250872,"['OAT', 'CKB']",0.9999897633382736,0,0,2
369,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8135058449050794,0.735712763690603,0.15185270905554032,"['EIF4A2', 'PRKCD', 'PIM2', 'EIF4B', 'MAPK3', 'EIF4G1']",0.9999897633382736,0,0,6
370,Male infertility WP4673,0.8135437036968037,0.796648289420262,0.16439286022648164,"['DDX4', 'ABCB1', 'HMGA1', 'TEX15', 'CLU', 'ETV5', 'AR', 'CCNA1', 'CYP26B1', 'MSH5', 'DND1', 'AHRR', 'RAG1']",0.9999897633382736,0,0,13
371,ErbB signaling pathway WP673,0.8175947330791714,0.787177611121273,0.15852851950393526,"['PRKCG', 'SHC4', 'CDKN1A', 'JUN', 'CDKN1B', 'PDPK1', 'BAD', 'PAK6', 'NRG1', 'ELK1', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,12
372,Neovascularisation processes WP4331,0.8223732946626602,0.6658194211772861,0.13020821678028807,"['JAG1', 'RELB', 'MAPK3']",0.9999897633382736,0,0,3
373,One-carbon metabolism WP241,0.8223732946626602,0.6658194211772861,0.13020821678028807,"['AHCY', 'SHMT2', 'MAT2B']",0.9999897633382736,0,0,3
374,IL-5 signaling pathway WP127,0.8225326826645489,0.6903991370010788,0.13488125056806738,"['GSK3A', 'JUN', 'ELK1', 'MAPK3']",0.9999897633382736,0,0,4
375,Hepatitis B infection WP4666,0.8242461903618097,0.8076661327402047,0.15611057146717808,"['PRKCG', 'JUN', 'EGR2', 'CDKN1A', 'EGR3', 'PCNA', 'ATP6AP1', 'YWHAB', 'BAD', 'NFATC2', 'ELK1', 'CREB3', 'IRF3', 'CYCS', 'FADD', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,17
376,Biotin Metabolism (including IEMs) WP5031,0.8260528103763064,0.5827777777777777,0.1113668358185848,['ACACB'],0.9999897633382736,0,0,1
377,Cancer immunotherapy by CTLA4 blockade WP4582,0.8260528103763064,0.5827777777777777,0.1113668358185848,['PPP2CA'],0.9999897633382736,0,0,1
378,Estrogen Receptor Pathway WP2881,0.8260528103763064,0.5827777777777777,0.1113668358185848,['JUN'],0.9999897633382736,0,0,1
379,Serotonin and anxiety-related events WP3944,0.8260528103763064,0.5827777777777777,0.1113668358185848,['GRIN2D'],0.9999897633382736,0,0,1
380,Ebstein-Barr virus LMP1 signaling WP262,0.8292881523508104,0.6215036378334681,0.1163377705983808,"['NFKBIA', 'HSP90AA1']",0.9999897633382736,0,0,2
381,Purine metabolism and related disorders WP4224,0.8292881523508104,0.6215036378334681,0.1163377705983808,"['PRPS1', 'APRT']",0.9999897633382736,0,0,2
382,MAPK Signaling Pathway WP382,0.8400295646883293,0.8357773414740429,0.14569119483511267,"['HSPB1', 'FGF1', 'ELK1', 'RELB', 'STMN1', 'MAP3K8', 'RAC1', 'HRAS', 'MAPK3', 'PRKCG', 'DUSP4', 'HSPA8', 'DAXX', 'JUN', 'DUSP2', 'JUND', 'DUSP3', 'DUSP1', 'PRKCD', 'MAPK8IP2', 'DUSP6', 'MAPK8IP1', 'DUSP7', 'CACNB1', 'FGF17', 'NR4A1', 'CACNB3', 'HSPA1B', 'HSPA1A', 'FGF10']",0.9999897633382736,0,0,30
383,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8415018874165389,0.6656842348589921,0.11487514629124033,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,4
384,DNA damage response (only ATM dependent) WP710,0.8419043469504658,0.7654776730119196,0.13173019035353303,"['FRAT1', 'JUN', 'CDKN1A', 'CDKN1B', 'CDKN2A', 'BAD', 'CCNG2', 'WNT7A', 'RAC1', 'WNT2', 'HRAS', 'BBC3']",0.9999897633382736,0,0,12
385,Regulation of Microtubule Cytoskeleton WP2038,0.8428791747498343,0.6851834218106506,0.1171195389762075,"['PARD6A', 'CFL2', 'STMN1', 'TPPP', 'RAC1']",0.9999897633382736,0,0,5
386,Lung fibrosis WP3624,0.8435342113730981,0.6354997610557659,0.1081333468097483,"['MT2A', 'CEBPB', 'FGF1']",0.9999897633382736,0,0,3
387,Resistin as a regulator of inflammation WP4481,0.8435342113730981,0.6354997610557659,0.1081333468097483,"['NFKBIA', 'PLCB2', 'MAPK3']",0.9999897633382736,0,0,3
388,Trans-sulfuration and one-carbon metabolism WP2525,0.8435342113730981,0.6354997610557659,0.1081333468097483,"['AHCY', 'SHMT2', 'MAT2B']",0.9999897633382736,0,0,3
389,Ras signaling WP4223,0.8444303971781213,0.8077494066755315,0.13658474223490746,"['PRKCG', 'SHC4', 'RAB5C', 'FLT3', 'BAD', 'RASAL1', 'FOXO4', 'PLD1', 'ELK1', 'GNG13', 'GNG10', 'GNG3', 'GNB2', 'PAK6', 'CALM3', 'RAC1', 'CALM1', 'CALM2', 'HRAS', 'ARF6', 'MAPK3']",0.9999897633382736,0,0,21
390,Wnt Signaling Pathway WP363,0.8459885768922177,0.6988056680161944,0.11687484403706104,"['PRKCG', 'GSK3A', 'FRAT1', 'NFATC2', 'PPARG', 'RAC1']",0.9999897633382736,0,0,6
391,Regulation of toll-like receptor signaling pathway WP1449,0.8469347237180489,0.7533050948574156,0.12514782207523564,"['NFKBIA', 'JUN', 'IRF3', 'TOLLIP', 'PELI3', 'PELI2', 'MAP3K8', 'FADD', 'RAC1', 'TMED7', 'MAPK3']",0.9999897633382736,0,0,11
392,Non-small cell lung cancer WP4255,0.8470062106976287,0.7353913766987391,0.12210971707924853,"['PRKCG', 'CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'CYCS', 'HRAS', 'FHIT', 'MAPK3']",0.9999897633382736,0,0,9
393,Chemokine signaling pathway WP3929,0.8511078016449188,0.775904104022755,0.12508853001838413,"['SHC4', 'VAV3', 'PRKCD', 'GNG13', 'VAV2', 'NFKBIA', 'GNG10', 'GNG3', 'GRK2', 'GNB2', 'RAC1', 'DOCK2', 'HRAS', 'PLCB2', 'MAPK3']",0.9999897633382736,0,0,15
394,EGF/EGFR signaling pathway WP437,0.8511488203644602,0.8061400637878701,0.1299242144960785,"['VAV3', 'NDUFA13', 'JUN', 'JUND', 'PCNA', 'PDPK1', 'PRKCD', 'PEBP1', 'FOXO4', 'PLD1', 'ELK1', 'EPN1', 'VAV2', 'CFL1', 'STMN1', 'AP2S1', 'FOSB', 'RAC1', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.9999897633382736,0,0,22
395,Immune response to tuberculosis WP4197,0.8529674242835816,0.582609135004042,0.09265461561921831,"['TAP1', 'IFIT1']",0.9999897633382736,0,0,2
396,miRNAs involvement in the immune response in sepsis WP4329,0.8529674242835816,0.582609135004042,0.09265461561921831,"['NFKBIA', 'RELB']",0.9999897633382736,0,0,2
397,NAD+ biosynthetic pathways WP3645,0.8529674242835816,0.582609135004042,0.09265461561921831,"['TDO2', 'ACMSD']",0.9999897633382736,0,0,2
398,Vitamin D in inflammatory diseases WP4482,0.8529674242835816,0.582609135004042,0.09265461561921831,"['NFKBIA', 'DUSP1']",0.9999897633382736,0,0,2
399,Head and Neck Squamous Cell Carcinoma WP4674,0.8545156024933616,0.7165565390849021,0.11265738981056327,"['FKBP1A', 'CDKN1A', 'PDPK1', 'CDKN2A', 'DDIT4', 'KEAP1', 'FADD', 'HRAS']",0.9999897633382736,0,0,8
400,Alanine and aspartate metabolism WP106,0.8567856182563184,0.517979797979798,0.08006286594290932,['GOT2'],0.9999897633382736,0,0,1
401,Nanoparticle triggered regulated necrosis WP2513,0.8567856182563184,0.517979797979798,0.08006286594290932,['FADD'],0.9999897633382736,0,0,1
402,Osteoclast Signaling WP12,0.8567856182563184,0.517979797979798,0.08006286594290932,['ATP6V1G1'],0.9999897633382736,0,0,1
403,Osteopontin Signaling WP1434,0.8567856182563184,0.517979797979798,0.08006286594290932,['MAPK3'],0.9999897633382736,0,0,1
404,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.8567856182563184,0.517979797979798,0.08006286594290932,['IRF3'],0.9999897633382736,0,0,1
405,Pancreatic adenocarcinoma pathway WP4263,0.8582300950541858,0.7423229561689744,0.11348858975039522,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'PRKCD', 'PEBP1', 'PAK6', 'RAC1', 'PLD1', 'DUSP6', 'MAPK3']",0.9999897633382736,0,0,11
406,Small cell lung cancer WP4658,0.8582300950541858,0.7423229561689744,0.11348858975039522,"['NFKBIA', 'CDKN1A', 'CDKN1B', 'GADD45B', 'LAMA4', 'LAMA3', 'CKS2', 'FN1', 'CYCS', 'FHIT', 'SKP1']",0.9999897633382736,0,0,11
407,Histone Modifications WP2369,0.858608123008073,0.6655489391223912,0.10145805228853934,"['SET', 'H3F3B', 'H3F3A', 'HIST1H4C', 'EZH2']",0.9999897633382736,0,0,5
408,Allograft Rejection WP2328,0.8587351297989931,0.6426738087267047,0.09787584812133558,"['TUBA1B', 'ABCB1', 'HLA-DQB1', 'C2']",0.9999897633382736,0,0,4
409,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8587351297989931,0.6426738087267047,0.09787584812133558,"['ACTC1', 'PAK6', 'ACTB', 'ACTG1']",0.9999897633382736,0,0,4
410,Leptin signaling pathway WP2034,0.8592465198364818,0.7226493157960947,0.10962547736835518,"['GSK3A', 'BAD', 'CFL2', 'LEPR', 'RAC1', 'ELK1', 'HRAS', 'ACACB', 'MAPK3']",0.9999897633382736,0,0,9
411,Kit receptor signaling pathway WP304,0.8604156833149225,0.6817023797768342,0.10248689978398584,"['TEC', 'BAD', 'MITF', 'JUNB', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,6
412,Lipid Metabolism Pathway WP3965,0.8624716590980207,0.6078165931187257,0.08992828210062986,"['ACLY', 'PRKAR1A', 'FASN']",0.9999897633382736,0,0,3
413,Oxysterols derived from cholesterol WP4545,0.8624716590980207,0.6078165931187257,0.08992828210062986,"['CYP39A1', 'DBP', 'ACOT6']",0.9999897633382736,0,0,3
414,TLR4 Signaling and Tolerance WP3851,0.8736105569524617,0.5482904560369014,0.07408532971418796,"['NFKBIA', 'IRF3']",0.9999897633382736,0,0,2
415,Notch Signaling Pathway Netpath WP61,0.8737070352796567,0.6654135338345865,0.08983758728822908,"['PSENEN', 'CDKN1A', 'JAG1', 'HEY1', 'SKP1', 'DLL3']",0.9999897633382736,0,0,6
416,DNA damage response WP707,0.8756275895237454,0.6791970433373835,0.09020715088427754,"['CDKN1A', 'CDKN1B', 'GADD45B', 'CDK5', 'H2AFX', 'CYCS', 'BBC3']",0.9999897633382736,0,0,7
417,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8793625157847939,0.5824403558431055,0.07487739516847161,"['NFKBIA', 'JUN', 'IRF3']",0.9999897633382736,0,0,3
418,Regulation of Actin Cytoskeleton WP51,0.8802229915071693,0.7606711608846624,0.0970464298777668,"['CHRM1', 'CHRM5', 'FN1', 'BRK1', 'FGF1', 'ACTB', 'ACTG1', 'FGF17', 'CFL2', 'TMSB4X', 'CFL1', 'PAK6', 'RAC1', 'PFN1', 'GIT1', 'FGF10', 'MAPK3']",0.9999897633382736,0,0,17
419,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8813654241390388,0.6984394000810701,0.08820099180984149,"['FZD1', 'PDPK1', 'NRG1', 'RAC1', 'IL6ST', 'CALM1', 'PLCB2', 'CALM2', 'MAPK3']",0.9999897633382736,0,0,9
420,Cysteine and methionine catabolism WP4504,0.8820903306816703,0.46614141414141413,0.058482480549048976,['AHCY'],0.9999897633382736,0,0,1
421,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.8820903306816703,0.46614141414141413,0.058482480549048976,['EXPH5'],0.9999897633382736,0,0,1
422,Disorders of Folate Metabolism and Transport WP4259,0.8820903306816703,0.46614141414141413,0.058482480549048976,['SHMT2'],0.9999897633382736,0,0,1
423,FOXA2 pathway WP5066,0.8820903306816703,0.46614141414141413,0.058482480549048976,['FASN'],0.9999897633382736,0,0,1
424,GPR40 Pathway WP3958,0.8820903306816703,0.46614141414141413,0.058482480549048976,['PLCB2'],0.9999897633382736,0,0,1
425,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.8820903306816703,0.46614141414141413,0.058482480549048976,['JAG1'],0.9999897633382736,0,0,1
426,Mammalian disorder of sexual development WP4842,0.8820903306816703,0.46614141414141413,0.058482480549048976,['AMH'],0.9999897633382736,0,0,1
427,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.8820903306816703,0.46614141414141413,0.058482480549048976,['NFKBIA'],0.9999897633382736,0,0,1
428,"NAD metabolism, sirtuins and aging WP3630",0.8820903306816703,0.46614141414141413,0.058482480549048976,['PPARG'],0.9999897633382736,0,0,1
429,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.8820903306816703,0.46614141414141413,0.058482480549048976,['IL6ST'],0.9999897633382736,0,0,1
430,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8859215611233062,0.6498823086338387,0.07871820585775266,"['UPF1', 'PCNA', 'TRIM28', 'CDK5', 'CDKN2A', 'H2AFX']",0.9999897633382736,0,0,6
431,Amino Acid metabolism WP3925,0.8913065488683998,0.686929768019829,0.07904285167032325,"['ACLY', 'TPO', 'LDHA', 'PKM', 'OAT', 'TDO2', 'MDH2', 'ALDH1A1', 'GOT2']",0.9999897633382736,0,0,9
432,Retinoblastoma gene in cancer WP2446,0.8913065488683998,0.686929768019829,0.07904285167032325,"['CDKN1A', 'CDKN1B', 'PCNA', 'TFDP2', 'H2AFZ', 'STMN1', 'MCM3', 'MCM4', 'DCK']",0.9999897633382736,0,0,9
433,1q21.1 copy number variation syndrome WP4905,0.891551021993498,0.5177849636216654,0.059437888268885734,"['PYGO2', 'ACP6']",0.9999897633382736,0,0,2
434,Genes controlling nephrogenesis WP4823,0.891551021993498,0.5177849636216654,0.059437888268885734,"['ITGA8', 'ETV4']",0.9999897633382736,0,0,2
435,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.891551021993498,0.5177849636216654,0.059437888268885734,"['CEBPA', 'CEBPB']",0.9999897633382736,0,0,2
436,PKC-gamma calcium signaling pathway in ataxia WP4760,0.891551021993498,0.5177849636216654,0.059437888268885734,"['PRKCG', 'PLCB2']",0.9999897633382736,0,0,2
437,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8971197556293792,0.6350570482149429,0.06894555205776304,"['MYO1E', 'CDKN1A', 'CDKN1B', 'PCNA', 'JAG1', 'SYNPO']",0.9999897633382736,0,0,6
438,miRNA regulation of DNA damage response WP1530,0.8975015166050084,0.6519157553665451,0.0704984754103132,"['CDKN1A', 'CDKN1B', 'GADD45B', 'CDK5', 'H2AFX', 'CYCS', 'BBC3']",0.9999897633382736,0,0,7
439,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9011243666194062,0.5822714401294499,0.060621443671243704,"['IRF3', 'BSG', 'CXCL17', 'FADD']",0.9999897633382736,0,0,4
440,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.9029253486127071,0.4237281910009183,0.043269173461251025,['CCK'],0.9999897633382736,0,0,1
441,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.9070992322271881,0.4904905756711909,0.04782451241452324,"['FSHR', 'MAPK3']",0.9999897633382736,0,0,2
442,Autophagy WP4923,0.9076974503617584,0.5375439360477775,0.05205799113949196,"['MAP1LC3B', 'ATG101', 'ATG9A']",0.9999897633382736,0,0,3
443,Melatonin metabolism and effects WP3298,0.9076974503617584,0.5375439360477775,0.05205799113949196,"['PER2', 'CALM1', 'CALM2']",0.9999897633382736,0,0,3
444,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9089070115788926,0.5970799738505121,0.057028593557031285,"['NFKBIA', 'TOLLIP', 'MAP3K8', 'ELK1', 'MAPK3']",0.9999897633382736,0,0,5
445,Integrated Cancer Pathway WP1971,0.9125210982759449,0.5645778170050014,0.051683752552229074,"['CDKN1A', 'CDKN1B', 'BAD', 'BBC3']",0.9999897633382736,0,0,4
446,Fatty acid transporters WP5061,0.9200799114104208,0.3883838383838384,0.03235033568637114,['FABP7'],0.9999897633382736,0,0,1
447,"GPCRs, Class B Secretin-like WP334",0.9200799114104208,0.3883838383838384,0.03235033568637114,['ADGRG2'],0.9999897633382736,0,0,1
448,IL-9 signaling pathway WP22,0.9200799114104208,0.3883838383838384,0.03235033568637114,['MAPK3'],0.9999897633382736,0,0,1
449,Omega-9 FA synthesis WP4724,0.9200799114104208,0.3883838383838384,0.03235033568637114,['FASN'],0.9999897633382736,0,0,1
450,DNA Mismatch Repair WP531,0.9205402864345139,0.46592562651576397,0.0385760855511368,"['PCNA', 'POLE3']",0.9999897633382736,0,0,2
451,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9205402864345139,0.46592562651576397,0.0385760855511368,"['H3F3B', 'H3F3A']",0.9999897633382736,0,0,2
452,Integrin-mediated Cell Adhesion WP185,0.925280988713764,0.655449322047451,0.050900762859707085,"['VAV3', 'CAPNS1', 'PDPK1', 'ITGA11', 'ITGA8', 'PAK6', 'RAC1', 'ITGA5', 'HRAS', 'VAV2']",0.9999897633382736,0,0,10
453,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9275943439738685,0.5678554155027589,0.04268045090438419,"['GRIN3A', 'DLG4', 'HRAS', 'MAPK3', 'GRIN2D']",0.9999897633382736,0,0,5
454,IL-2 signaling pathway WP49,0.9298587457615488,0.49906129050892495,0.03629302993825694,"['JUN', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,3
455,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9310555900633691,0.620583468395462,0.04433218274630392,"['CREB3', 'TPO', 'THRA', 'BAD', 'ITPR2', 'PRKCQ', 'PPARG', 'HRAS']",0.9999897633382736,0,0,8
456,Gastric Cancer Network 2 WP2363,0.9321332282410949,0.4437001963275205,0.03118303937583372,"['S100A6', 'CACYBP']",0.9999897633382736,0,0,2
457,MTHFR deficiency WP4288,0.9321332282410949,0.4437001963275205,0.03118303937583372,"['CYCS', 'GRIN2D']",0.9999897633382736,0,0,2
458,Acute viral myocarditis WP4298,0.9329654831466917,0.5819331983805668,0.04037864211712454,"['ENDOG', 'CYCS', 'ACTB', 'EIF4G2', 'MAPK3', 'EIF4G1']",0.9999897633382736,0,0,6
459,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9329654831466917,0.5819331983805668,0.04037864211712454,"['IL15RA', 'DUSP2', 'TRIM28', 'STMN1', 'IL6ST', 'MAPK3']",0.9999897633382736,0,0,6
460,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.934203944430772,0.3584770784770785,0.02439813230692601,['LTB4R'],0.9999897633382736,0,0,1
461,Kennedy pathway from sphingolipids WP3933,0.934203944430772,0.3584770784770785,0.02439813230692601,['PCYT2'],0.9999897633382736,0,0,1
462,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.934203944430772,0.3584770784770785,0.02439813230692601,['FRAT1'],0.9999897633382736,0,0,1
463,Pyrimidine metabolism and related diseases WP4225,0.934203944430772,0.3584770784770785,0.02439813230692601,['TYMP'],0.9999897633382736,0,0,1
464,Riboflavin and CoQ disorders WP5037,0.934203944430772,0.3584770784770785,0.02439813230692601,['RFK'],0.9999897633382736,0,0,1
465,SARS coronavirus and innate immunity WP4912,0.934203944430772,0.3584770784770785,0.02439813230692601,['IRF3'],0.9999897633382736,0,0,1
466,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9355917738588949,0.5542868705555877,0.036902223025617784,"['NFKBIA', 'TKFC', 'IRF3', 'ISG15', 'FADD']",0.9999897633382736,0,0,5
467,p53 transcriptional gene network WP4963,0.9355917738588949,0.5542868705555877,0.036902223025617784,"['BTG2', 'CDKN1A', 'DRAM1', 'ISG15', 'BBC3']",0.9999897633382736,0,0,5
468,TGF-beta Signaling Pathway WP366,0.9365241981927723,0.6782849309504468,0.04448187046751437,"['KLF10', 'JUN', 'CDKN1A', 'JUND', 'CITED1', 'FN1', 'NEDD9', 'RUNX2', 'PJA1', 'PARD6A', 'FOSB', 'RAC1', 'JUNB', 'SKP1']",0.9999897633382736,0,0,14
469,Disruption of postsynaptic signaling by CNV WP4875,0.9389990710361442,0.4818104494053014,0.030325529875567515,"['YWHAG', 'MAPK3', 'GRIN2D']",0.9999897633382736,0,0,3
470,Hedgehog Signaling Pathway WP4249,0.9389990710361442,0.4818104494053014,0.030325529875567515,"['GRK2', 'EVC', 'HHIP']",0.9999897633382736,0,0,3
471,Sphingolipid pathway WP1422,0.9421113558738125,0.4234952597927537,0.025253784299201703,"['PPP2CA', 'SERINC1']",0.9999897633382736,0,0,2
472,IL-1 signaling pathway WP195,0.9427876442936535,0.5413494207222385,0.03189317526247176,"['NFKBIA', 'JUN', 'TOLLIP', 'PELI2', 'MAPK3']",0.9999897633382736,0,0,5
473,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.9458326421688555,0.33284271284271283,0.018535889725645203,['FN1'],0.9999897633382736,0,0,1
474,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9458326421688555,0.33284271284271283,0.018535889725645203,['ACLY'],0.9999897633382736,0,0,1
475,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.9470254263596046,0.46570966437525274,0.025348268163950863,"['JUN', 'JUNB', 'MAPK3']",0.9999897633382736,0,0,3
476,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9470254263596046,0.46570966437525274,0.025348268163950863,"['SLC12A5', 'GABRD', 'GABRG3']",0.9999897633382736,0,0,3
477,Type 2 papillary renal cell carcinoma WP4241,0.9470254263596046,0.46570966437525274,0.025348268163950863,"['CDKN1A', 'EGLN2', 'ELOB']",0.9999897633382736,0,0,3
478,PPAR signaling pathway WP3942,0.9472391897090634,0.503367445115018,0.027284348506445195,"['PDPK1', 'FABP7', 'LPL', 'PPARG']",0.9999897633382736,0,0,4
479,Ethanol effects on histone modifications WP3996,0.9506832342087836,0.40504727426101017,0.02048500625217339,"['AHCY', 'ALDH1A1']",0.9999897633382736,0,0,2
480,Fluoropyrimidine Activity WP1601,0.9506832342087836,0.40504727426101017,0.02048500625217339,"['UCK1', 'TYMP']",0.9999897633382736,0,0,2
481,IL17 signaling pathway WP2112,0.9506832342087836,0.40504727426101017,0.02048500625217339,"['CEBPB', 'MAPK3']",0.9999897633382736,0,0,2
482,Insulin Signaling WP481,0.9521324836076366,0.6898688695563695,0.033838820298350586,"['EGR1', 'XBP1', 'JUN', 'ARF1', 'GSK3A', 'PRKCH', 'PDPK1', 'PRKCD', 'ELK1', 'EHD1', 'EHD2', 'PFKL', 'MAP3K8', 'PRKCQ', 'RAC1', 'HRAS', 'VAMP2', 'ARF6', 'MAPK3']",0.9999897633382736,0,0,19
483,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.9554067148790638,0.31062626262626264,0.014170195351660836,['MAPK3'],0.9999897633382736,0,0,1
484,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.9554067148790638,0.31062626262626264,0.014170195351660836,['EZH2'],0.9999897633382736,0,0,1
485,Kallmann's Syndrome WP5074,0.9554067148790638,0.31062626262626264,0.014170195351660836,['PRKCQ'],0.9999897633382736,0,0,1
486,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.9554067148790638,0.31062626262626264,0.014170195351660836,['FASN'],0.9999897633382736,0,0,1
487,Statin inhibition of cholesterol production WP430,0.9554067148790638,0.31062626262626264,0.014170195351660836,['LPL'],0.9999897633382736,0,0,1
488,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.9554067148790638,0.31062626262626264,0.014170195351660836,['IRF3'],0.9999897633382736,0,0,1
489,ESC Pluripotency Pathways WP3931,0.9572453753511514,0.6040593631834508,0.026394687875398292,"['FZD1', 'FGF17', 'JUN', 'WNT7A', 'FGF1', 'IL6ST', 'ELK1', 'WNT2', 'HRAS', 'FGF10']",0.9999897633382736,0,0,10
490,Endoderm differentiation WP2853,0.9572566511813114,0.6269881803589669,0.027389188924267553,"['VAV3', 'DUSP4', 'MAD2L2', 'DUSP5', 'DUSP2', 'TRIM5', 'C1QBP', 'TCEAL2', 'SLC2A12', 'PAF1', 'EZH2', 'NME1']",0.9999897633382736,0,0,12
491,AMP-activated protein kinase (AMPK) signaling WP1403,0.9572745551954652,0.5369822485207101,0.023447349826991006,"['CCNA1', 'CDKN1A', 'FASN', 'LEPR', 'EEF2', 'ACACB']",0.9999897633382736,0,0,6
492,Hippo-Merlin Signaling Dysregulation WP4541,0.9576851412629456,0.58966527172765,0.025494895998063826,"['PPP1CC', 'PRKAR1A', 'FLT3', 'ITGA11', 'ITGA8', 'PAK6', 'ITGA5', 'HRAS', 'CDH7']",0.9999897633382736,0,0,9
493,Nanoparticle-mediated activation of receptor signaling WP2643,0.9580341525349328,0.38813662085691186,0.01664013569491284,"['FN1', 'HRAS']",0.9999897633382736,0,0,2
494,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9626710153875118,0.5638721084426108,0.021451696908143195,"['PRKCG', 'SHC4', 'PDPK1', 'BAD', 'PDGFD', 'NRG1', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,8
495,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9632890630659865,0.29118686868686866,0.010890896396901037,['FLT3'],0.9999897633382736,0,0,1
496,Fragile X Syndrome  WP4549,0.9646981387928453,0.6318014401425947,0.02270696657898459,"['DUSP3', 'CDKN2A', 'TECR', 'CLTB', 'AKAP5', 'EEF1A1', 'GRIP1', 'PRKAR1A', 'DLG4', 'CLTCL1', 'AP2S1', 'GABRD', 'AP2M1', 'EIF4G1']",0.9999897633382736,0,0,14
497,Mesodermal commitment pathway WP2857,0.9733807937741696,0.5810851926977688,0.01567762785729405,"['VAV3', 'PPP2CA', 'ARL4A', 'TRIM28', 'PRKAR1A', 'TRIM5', 'C1QBP', 'BHLHE40', 'SLC2A12', 'RPL38', 'AMH']",0.9999897633382736,0,0,11
498,Angiogenesis WP1539,0.9751211176712296,0.2587878787878788,0.006519796348357853,['TIMP2'],0.9999897633382736,0,0,1
499,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9751211176712296,0.2587878787878788,0.006519796348357853,['FLT3'],0.9999897633382736,0,0,1
500,Mitochondrial Gene Expression WP391,0.9751211176712296,0.2587878787878788,0.006519796348357853,['HCFC1'],0.9999897633382736,0,0,1
501,Fatty acid beta-oxidation WP143,0.9782179780692771,0.3325730453863033,0.007324173806941825,"['TPI1', 'LPL']",0.9999897633382736,0,0,2
502,EPO Receptor Signaling WP581,0.9795194879650906,0.24514619883040936,0.005072846075374299,['MAPK3'],0.9999897633382736,0,0,1
503,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9795194879650906,0.24514619883040936,0.005072846075374299,['IRF3'],0.9999897633382736,0,0,1
504,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9814476761076301,0.47298428600837167,0.008857376564898871,"['ACLY', 'GSK3A', 'RBP4', 'FASN', 'LPL', 'PPARG']",0.9999897633382736,0,0,6
505,BDNF-TrkB Signaling WP3676,0.9815530569644881,0.32107713321997045,0.005978202475642381,"['DLG4', 'HRAS']",0.9999897633382736,0,0,2
506,Sphingolipid Metabolism (general overview) WP4725,0.98314044689622,0.23286868686868686,0.003959534573011184,['SMPD1'],0.9999897633382736,0,0,1
507,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9861213550594816,0.22176046176046177,0.003099291792043598,['HRAS'],0.9999897633382736,0,0,1
508,Sphingolipid Metabolism (integrated pathway) WP4726,0.9861213550594816,0.22176046176046177,0.003099291792043598,['SMPD1'],0.9999897633382736,0,0,1
509,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9868005258609103,0.30031032414530473,0.0039903318186651675,"['IGFBP5', 'PLD1']",0.9999897633382736,0,0,2
510,Notch Signaling WP268,0.9868005258609103,0.30031032414530473,0.0039903318186651675,"['JAG1', 'DLL3']",0.9999897633382736,0,0,2
511,Nucleotide Excision Repair WP4753,0.9896241100831711,0.3404377027999961,0.003550797492405514,"['PCNA', 'CETN2', 'POLE3']",0.9999897633382736,0,0,3
512,Pathways affected in adenoid cystic carcinoma WP3651,0.989749963302611,0.37969751007199,0.003911996895289387,"['MORF4L1', 'CEBPA', 'CNTN6', 'HRAS']",0.9999897633382736,0,0,4
513,Joubert Syndrome WP4656,0.9900875272942009,0.4358426113360324,0.004341832867434234,"['CETN2', 'ANKS6', 'ARL2', 'PDE6B', 'B9D2', 'ZNF423']",0.9999897633382736,0,0,6
514,Interferon type I signaling pathways WP585,0.9911057389094087,0.3323031598405638,0.0029688134246223684,"['RACK1', 'RAC1', 'EIF4B']",0.9999897633382736,0,0,3
515,Neural Crest Differentiation WP2064,0.9911174402132562,0.37207119741100325,0.0033197103432759823,"['MITF', 'CDH7', 'RHOB', 'DLL3']",0.9999897633382736,0,0,4
516,DNA IR-damage and cellular response via ATR WP4016,0.9912794724398061,0.42909996885705387,0.0037583895970003775,"['UPF1', 'FEN1', 'PCNA', 'TRIM28', 'H2AFX', 'USP1']",0.9999897633382736,0,0,6
517,Phosphoinositides metabolism WP4971,0.9923819536429017,0.32454696771645397,0.0024818794302499045,"['PIP4P1', 'PLCH2', 'PLCB2']",0.9999897633382736,0,0,3
518,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9956817652815849,0.1723905723905724,0.0007460348935089153,['PRKCQ'],0.9999897633382736,0,0,1
519,mRNA Processing WP411,0.9965333674875587,0.48842276144907726,0.001696123845243094,"['SF3B4', 'SF3B5', 'LSM7', 'SF3A1', 'HNRNPK', 'CD2BP2', 'CSTF2T', 'SNRPE', 'SNU13', 'HNRNPH2', 'HNRNPA1', 'HNRNPAB']",0.9999897633382736,0,0,12
520,Splicing factor NOVA regulated synaptic proteins WP4148,0.9966282686369922,0.2385423792052733,0.0008056598201710726,"['CADM3', 'NCDN']",0.9999897633382736,0,0,2
521,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9971638818628027,0.23255860953920776,0.000660500762932972,"['FASN', 'DHCR24']",0.9999897633382736,0,0,2
522,Energy Metabolism WP1541,0.9971638818628027,0.23255860953920776,0.000660500762932972,"['PPARG', 'MEF2D']",0.9999897633382736,0,0,2
523,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9971638818628027,0.23255860953920776,0.000660500762932972,"['ATG101', 'CP']",0.9999897633382736,0,0,2
524,MECP2 and Associated Rett Syndrome WP3584,0.99725503042587,0.32052784287467917,0.0008810489566176145,"['GPRIN1', 'TAP1', 'FKBP5', 'EZH2']",0.9999897633382736,0,0,4
525,Integrated breast cancer pathway WP1984,0.9977755493779719,0.4717009685230024,0.0010504442771866018,"['AR', 'PLK3', 'JUN', 'GSK3A', 'GDI1', 'BAD', 'PHB', 'FADD', 'RAC1', 'FAU', 'JAKMIP1', 'FOSL2']",0.9999897633382736,0,0,12
526,Thermogenesis WP4321,0.9987195419329412,0.37345847125040155,0.00047850433000921097,"['ADCY10', 'CREB3', 'GNAS', 'PPARG', 'HRAS', 'ACTB', 'ACTG1']",0.9999897633382736,0,0,7
527,Rett syndrome causing genes WP4312,0.998813053910879,0.2066289409862571,0.00024540308234553875,"['IMPDH2', 'GABRD']",0.9999897633382736,0,0,2
528,Ciliopathies WP4803,0.9988382026733609,0.48265440877691995,0.0005610725912726501,"['DNAH11', 'DCDC2', 'WDR34', 'BBS10', 'EVC', 'ARL2BP', 'MAK', 'ANKS6', 'CCDC65', 'B9D2', 'CCNQ', 'ZNF423', 'CCDC151', 'CCNO', 'CNGB1']",0.9999897633382736,0,0,15
529,DNA Repair Pathways Full Network WP4946,0.9991468811509197,0.3975447333371938,0.00033929765656323045,"['FEN1', 'NEIL2', 'PCNA', 'CENPX', 'CETN2', 'H2AFX', 'POLE3', 'USP1', 'APEX2']",0.9999897633382736,0,0,9
530,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9997543973145413,0.34656689740832186,8.512821498164649e-05,"['GSK3A', 'THRA', 'PDPK1', 'FASN', 'LPL', 'MAP3K8', 'HRAS', 'MAPK3']",0.9999897633382736,0,0,8
531,Ectoderm Differentiation WP2858,0.9998108858918523,0.3212989585714343,6.0767912214910417e-05,"['SDCBP', 'ARHGDIG', 'ST8SIA4', 'UBTF', 'JAKMIP1', 'CELSR2', 'LY6E']",0.9999897633382736,0,0,7
532,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999897633382736,0.19301173139158576,1.97580591632669e-06,"['BBS10', 'EVC', 'DYNLL1', 'WDR34']",0.9999897633382736,0,0,4
